Skip to content

Professor Paul Heath

Professor of Paediatric Infectious Diseases
Clinical academic

Paul Heath is Professor of Paediatric Infectious Diseases and a Consultant in Paediatric Infectious Diseases. He is Director of the Vaccine Institute.

Paul Heath is a Professor and Honorary Consultant in Paediatric Infectious Diseases at St George's University Hospitals NHS Foundation Trust and St George’s, University of London, where he is Director of the Vaccine Institute. His training in paediatrics and infectious diseases was at the Royal Children’s Hospital, Melbourne, Australia; the John Radcliffe Hospital, Oxford; and St George’s Hospital, London. His research interests are in the epidemiology of vaccine preventable diseases, in clinical vaccine trials, particularly in at-risk groups and in perinatal infections. He coordinates the UK Paediatric Vaccine Group (UKPVG), is co-chair of the UK Infectious Diseases Vaccine Research Forum (UKID-VRF), is a member of the NICE meningitis and neonatal infection guideline development committees and is a member of the JCVI, chairing the JCVI horizon scanning sub-committee. He is the Chair of the SGUL Research Ethics Committee, NIHR Speciality Lead for Children’s research for South London CRN and a member of the WHO GBS Working Group.

Professor Heath's particular research interests are in the epidemiology of vaccine-preventable diseases, in clinical vaccine trials, particularly in at-risk groups, and in perinatal infections. He coordinates a national neonatal infection network called neonIN (https://www.neonin.org.uk) which collects data on pathogens causing neonatal infections and aims to focus appropriate treatments and prevention strategies.

Professor Heath’s research concentrates on all aspects of perinatal and neonatal infection. Neonates, particularly when premature, are at high-risk of infections, indeed their risk is higher than at any other age in life. Infections can be transmitted by the mother in utero, during delivery and breastfeeding (vertical transmission), or from the environment after delivery (horizontal transmission). The most frequent cause of serious bacterial infection in the first three months of life is Group B streptococcus (GBS) and this has been a major focus of Prof Heath`s work, having initially described the burden of disease in the UK in 2000/1 and 2014/5, and more recently globally.
 
Defining the epidemiology of all neonatal infections has been an important aspect of his ongoing work with the aim of formulating research priorities and this has been facilitated through the establishment of neonIN as well as through separate specific national surveillance studies on neonatal meningitis (2012), GBS (2001, 2014), Listeria (2019) and HSV (2022). Prevention of GBS infection has become a major priority but current antibiotic-based strategies are poorly applied and a vaccine approach will be critical. Knowledge of serocorrelates of protection will be critical to vaccine licensure and he is leading a national MRC-funded serocorrelates study (iGBS3). Pregnancy is increasingly the platform for new vaccines such as GBS and he has lead a number of maternal vaccine studies, including studies of pertussis (optimal timing), RSV, COVID-19 and GBS vaccines. This work includes pregnancy studies performed in Uganda, through collaboration with Prof Kirsty Le Doare. 

Management of established neonatal infections is potentially difficult because of growing antimicrobial resistance, again of vital importance to monitor through longitudinal surveillance systems (neonIN) as well as globally (neosep). Knowledge of the pharmacokinetics and pharmacodynamics of new, or even old antimicrobials, for the treatment of these infections in neonates is poor and this has been an important area for the CNPI AMR group, led by Prof Mike Sharland, including coordinating trials such as on the use of meropenem in neonatal meningitis (neomero2 ) and the monitoring of gentamicin and vancomycin in neonatal infections (neoGent and neoVanc).

The group has a longstanding interest in clinical trials of new or modified vaccines, in healthy infants, children and adolescents as well as in at-risk groups, for example studies on the immunogenicity of pandemic H1N1 influenza vaccine in children with cancer and HIV and optimal schedules for vaccines in preterm infants. The majority of these studies are conducted in collaboration with other major paediatric vaccine centres in the UK through the UK Paediatric Vaccine Group (UKPVG), for which Prof Heath is the national coordinator. 

 

  • Booy R, Heath PT, Slack MPE, Begg N, Moxon ER. Surveillance of vaccine failures following primary immunisation of infants with Hib conjugate vaccine: Evidence for protection without boosting. Lancet 1997;349:1197-202.
  • Heath PT, Bowen Morris J, Griffiths D, Griffiths H, Crook D, Moxon ER. Antibody persistence and Hib carriage following infant immunisation with PRP-T. Arch Dis Child 1997;77:488-492.
  • Bell F, Heath P, Shackley F, et al. Effect of combination with an acellular pertussis, diphtheria, tetanus vaccine on antibody response to Hib vaccine (PRP-T). Vaccine 1998;16(6):637-642.
  • Coen PG, Heath PT, Barbour ML, Garnett GP. Mathematical Models Of Haemophilus influenzae Type b. Epidemiology and Infection. 1998;120:281-295 .
  • Moses Lahra M, Heath PT, Wilkinson AR, Jeffery HE, Isaacs D. Early-onset group B streptococcal neonatal infection in Oxford. Archives of Disease in Childhood (Fetal and Neonatal), 1998;79:F148-9.
  • Shackley F, Roberts P, Heath P, Bowler I, Saunders N. Trough only monitoring of vancomycin in neonates. Journal of Antimicrobial Chemotherapy 1998;41:141-2.
  • Coen PG, Heath PT, Garnett GP. The Hib immunization programme in the Oxford region: an analysis of the impact of vaccine administration on the incidence of disease. Epidemiology and Infection. 1999;123:389-402.
  • Bell F, Heath P, Shackley F, Maclennan J, Herbert M, Shearstone N, Diggle L, Moxon ER, Finn A. Poor response to Hib (PRP-T) vaccine when combined with an acellular pertussis/diphtheria/tetanus vaccine for primary immunization of infants. Biologicals 1999 Jun;27(2):113.
  • Bell F, Heath P, MacLennan J, Shackley F, Shearstone N, Diggle L, Thornton C, Griffiths H, Moxon ER, Finn A. Adverse effects and sero-responses to an acellular pertussis/diphtheria/ tetanus vaccine when combined with Hib vaccine in an accelerated schedule. European Journal of Pediatrics 1999;158:329-336
  • Moxon ER, Heath PT, Booy R, Azzopardi HJ, Slack MPE, Ramsay ME. The impact of Hib conjugate vaccines in preventing invasive H. influenzae diseases in the UK. Vaccine 1999:17 S11-S13.
  • Maclennan JM, Shackley F, Heath PT, Deeks JJ, Flamank C, Herbert M, Griffiths H, Hatzmann E, Goilav C, Moxon ER. Safety, Immunogenicity and Induction of Immunological Memory by a Serogroup C Meningococcal Conjugate Vaccine in Infants: A Randomised Controlled Trial. JAMA 2000;283:2795-2801.
  • Heath PT, Booy R, Azzopardi HJ, Slack MPE, Bowen-Morris J, Griffiths H, Ramsay ME, Deeks JJ, Moxon ER. Antibody Concentration and Clinical Protection After Hib Conjugate Vaccination in the United Kingdom. JAMA 2000; 284:2334-2340.
  • Heath PT, Booy R, Griffiths H, Clutterbuck E, Azzopardi HJ, Slack MPE, Fogarty J, Moloney AC, Moxon ER. Clinical and Immunological Risk Factors Associated with Hib Conjugate Vaccine Failure in Childhood. Clinical Infectious Diseases 2000; 31:973-80.
  • Heath PT, Booy R, Azzopardi HJ, Slack MPE, Fogarty J, Moloney AC, Ramsay ME, Moxon ER. Non Type b Haemophilus influenzae Disease: Clinical and Epidemiological Characteristics in the Hib Vaccine Era. Pediatr Infect Dis J 2001:20:300-5
  • Heath PT, Booy R, McVernon J, Griffiths H, Bowen-Morris J, Slack MPE, Moloney AC, Ramsay ME, Moxon ER. Hib Vaccination in Infants Born Prematurely. Archives of Disease in Childhood 2003;88:206-10.
  • N S Crowcroft, Robert Booy, Tim Harrison, Lin Spicer, Joseph Britto, Quen Mok, Paul Heath, Ian A Murdoch, Maria Zambon, Rob George, and Elizabeth Miller. Severe and unrecognised Pertussis in UK infants. Archives of Disease in Childhood 2003;88:802-6.
  • Luck S, Torry M, d'Agapeyeff K, Pitt A, Heath PT, Breathnach A, Bedford Russell A. Estimated early-onset group B streptococcal neonatal disease. Lancet 2003; 361:1953-4.
  • Ramsay ME, McVernon J, Andrews NJ, Heath PT, Slack MP. Estimating Hib vaccine effectiveness in England and Wales using the screening method. J Infect Dis 2003;188:481-5.
  • Heath PT, Balfour G, Weisner AM, Efstratiou A, Lamagni TL, Tighe H, O'Connell LAF, Cafferkey M, Verlander NQ, Nicoll A, AC McCartney. Group B streptococcal disease in UK and Irish infants < 90 days of age. Lancet 2004;363:292-4.
  • Rothstein, E.; Kohl, K. S.; Ball, L.; Halperin, S. A.; Halsey, N.; Hammer, S. J.; Heath, P. T.; Hennig, R.; Kleppinger, C.; Labadie, J.Nodule at injection site as an adverse event following immunization: case definition and guidelines for data collection, analysis, and presentation. Vaccine 2004;22: 575-585.
  • Weisner AM, Johnson AP, Lamagni TL, Arnold E, Warner M, Heath PT, Efstratiou A. Characterisation of Group B Streptococci from Infants with Invasive Disease in England and Wales. Clinical Infectious Disease 2004;38:1203-8.
  • Collins C L, Ruggeberg JU, Balfour G, Tighe H, Archer M, Bowen-Morris J, Diggle L, Borrow R, Balmer P, Buttery J P, Moxon E R, Pollard AJ, Heath P T. Immunogenicity and Immunological Memory of Meningococcal C Conjugate Vaccine in Premature infants. Pediatric Infectious Diseases Journal 2005;24(11):966-8.
  • Huo Z.  Sinha R.  McNeela EA.  Borrow R.  Giemza R.  Cosgrove C.  Heath PT.  Mills KH.  Rappuoli R.  Griffin GE.  Lewis DJ. Induction of protective serum meningococcal bactericidal and diphtheria-neutralizing antibodies and mucosal immunoglobulin A in volunteers by nasal insufflations of the Neisseria meningitidis serogroup C polysaccharide-CRM197 conjugate vaccine mixed with chitosan. Infection & Immunity 2005; 73(12):8256-65. · Haitham El Bashir, Paul T. Heath, Thomas Papa, Jens U Ruggeberg, Nik Johnson, Ruchi Sinha, Gail Balfour and Robert Booy. Antibody responses to meningococcal (groups A, C, Y and W135) polysaccharide diphtheria toxoid conjugate vaccine in children who previously received meningococcal C conjugate vaccine. Vaccine. 2006; 24:2544-9.  
  • David M. Vu, Paul T. Heath, Noel D. McCarthy, Andrew J.Pollard and Dan M. Granoff. Effectiveness Analyses May Underestimate Protection of Infants after Group C Meningococcal Immunization. The Journal of Infectious Diseases 2006;194(2):231-7.
  • Paul Clarke, Michael J Robinson, Ijaz Ahmad, Alison R Bedford-Russell, Jane E Connell, Peter J Powell, Paul T Heath. Response of steroid-treated former preterm infants to a single dose of meningococcal C conjugate vaccine. 2006;24(16):3273-8.
  • Nik G Johnson, Jens U Ruggeberg, Gail F Balfour, Y Chen Lee, Helen Liddy, Diane Irving, Joanna Sheldon, Mary PE Slack, Andrew J Pollard, Paul T Heath. Reemergence of Haemophilus influenzae type b associated with reduced antibody and avidity responses after primary immunization with acellular pertussis-containing combination vaccines. Emerging Infectious Diseases 2006 Jun;12(6):937-41.
  • Conterno LO, Silva Filho CR, Rüggeberg JU, Heath PT. Conjugate vaccines for preventing meningococcal C meningitis and septicaemia. Cochrane Database Syst Rev. 2006 Jul 19;3:CD001834 
  • Kohl KS, Ball L, Gidudu J, Hammer SJ, Halperin S, Heath P, Hennig R, Labadie J, Rothstein E, Schuind A, Varricchio F, Walop W; The Brighton Collaboration Local Reactions Working Group for Abscess at Injection Site. Abscess at injection site: Case definition and guidelines for collection, analysis, and presentation of immunization safety data. Vaccine. 2007 Aug 1;25(31):5821-38.
  • Jens U. Ruggeberg, Clare Collins, Paul Clarke, Nik Johnson, Ruchi Sinha, Neil Everest, John Chang, Elaine Stanford, Paul Balmer, Ray Borrow, Sarah Martin, Michael J. Robinson, E Richard Moxon, Andrew J. Pollard, Paul T. Heath. Immunogenicity and induction of immunological memory of the heptavalent pneumococcal conjugate vaccine in preterm UK infants. Vaccine. 2007 Jan 4;25(2):264-71.
  • Ladhani S, Slack PP, Heath PT, Ramsay ME. Changes in ascertainment of Hib and its influence on the estimation of disease incidence in the United Kingdom. Epidemiol Infect. 2007 Jul;135(5):861-7.
  • Patel SR, Ortín M, Cohen BJ, Borrow R, Irving D, Sheldon J, Heath PT. Re-immunization with measles, tetanus, poliovirus, Haemophilus influenzae type b, meningococcal C and pneumococcal vaccines in children following hematopoietic stem cell transplantation. Clin Infect Dis. 2007 Mar 1;44(5):625-34. ·       32.  Patel SR, Ortín M, Cohen BJ, Borrow R, Irving D, Sheldon J, Heath PT. Reimmunization of children after completion of standard chemotherapy for acute leukemia. Clin Infect Dis.2007 Mar 1;44(5):635-42. 
  • Pandemic flu: clinical management of patients with an influenza-like illness during an influenza pandemic. Paediatric Subgroup. Thomson A, Ajayi-Obe E, Coote N, Harnden A, Heath P, Mckenzie S.
  • Thorax 2007;62(Suppl I):i1–i13 and Journal of Infection 2006;53(Suppl 1):S1–S58.
  • Kohl KS, Walop W, Gidudu J, Ball L, Halperin S, Hammer SJ, Heath P, Hennig R, Rothstein E, Schuind A, Varricchio F; The Brighton Collaboration Local Reactions Working Group for Induration at or near Injection Site. Induration at or near injection site: Case definition and guidelines for collection, analysis, and presentation of immunization safety data. Vaccine. 2007 Aug 1;25(31):5839-57.
  • Halperin S, Kohl KS, Gidudu J, Ball L, Hammer SJ, Heath P, Hennig R, Labadie J, Rothstein E, Schuind A, Varricchio F, Walop W; The Brighton Collaboration Local Reaction Working Group for Cellulitis at Injection Site. Cellulitis at injection site: Case definition and guidelines for collection, analysis, and presentation of immunization safety data. Vaccine. 2007 Aug 1;25(31):5803-20
  • Kohl KS, Walop W, Gidudu J, Ball L, Halperin S, Hammer SJ, Heath P, Varricchio F, Rothstein E, Schuind A, Hennig R; The Brighton Collaboration Local Reaction Working Group for Swelling at or near Injection Site. Swelling at or near injection site: Case definition and guidelines for collection, analysis and presentation of immunization safety data. Vaccine. 2007 Aug 1;25(31):5858-74.
  • Crowcroft NS, Zambon M, Harrison TG, Mok Q, Heath P, Miller E. Respiratory syncytial virus infection in infants admitted to paediatric intensive care units in London, and in their families. Eur J Pediatr. 2007 May 31; [Epub ahead of print]
  • Roche A, Heath PT, Sharland M, Strachan D, Breathnach A, Haigh J, Young Y. Prevalence of nasopharyngeal carriage of pneumococcus in preschool children attending day care in London. Archives of Disease in Childhood 2007 Dec;92(12):1073-6.
  • S J C Cameron, G Allan, F Johnston, A Finn, PT Heath, R Booy. Severe complications of chickenpox in hospitalised children in the UK and Republic of Ireland. Archives of Disease in Childhood, 2007 Dec;92(12):1062-6.
  • Spyridis N, Chakraborty R, Sharland M, Heath PT. Early diagnosis of tuberculosis using an INFγ assay in a child with HIV-1 infection and a very low CD-4 count. Scandinavian Journal of Infectious Diseases 2007;39(10):919-21.
  • Lee YC, Kelly D, Yu L, Slack M, Booy R, Heath PT, Siegrist C, Moxon ER, Pollard AJ. Haemophilus influenzae type b vaccine failure in children is associated with inadequate production of high quality antibody. Clin Infect Dis. 2008 Jan 15;46(2):186-92.
  • Sarah Y Oh; David Griffiths; Tessa John; Yeh C Lee; Lymee M Yu; Noel McCarthy; Paul T Heath; Derrick Crook; Mary Ramsay; E. Richard Moxon; Andrew J. Pollard. School-age children: a reservoir for continued circulation of Haemophilus influenzae type b in the UK. Journal of Infectious Diseases 2008 May 1;197(9):1275-81. ·       Fernando A, Heath PT, Menson E. Antimicrobial policies in British and Irish neonatal units. Journal of J Antimicrob Chemother. 2008 Mar;61(3):743-5.
  • Ladhani S, Heath PT, Ramsay ME, Slack MP. Changes in antibiotic resistance rates of invasive Haemophilus influenzae isolates in England and Wales over the last 20 years. J Antimicrob Chemother. 2008 Oct;62(4):776-9.
  • Liz Schroeder, Stavros Petrou, Gail Balfour, Oya Edamma, Paul T. Heath. The economic costs of Group B Streptococcus (GBS) disease: prospective cohort study of infants with GBS disease in England. The European Journal of Health Economics 2009 Jul;10(3):275-85.
  • A local reaction at or near injection site: Case definition and guidelines for collection, analysis, and presentation of immunization safety data. Jane Gidudu, Katrin S. Kohl , Scott Halperin , Sandra Jo Hammer, Paul T. Heath , Renald Hennig, Bernard Hoet , Edward Rothstein , Anne Schuind, Frederick Varricchio , Wikke Walop, The Brighton Collaboration Local Reactions Working Group for A Local Reaction at or near Injection Site. Vaccine. 2008 9;26(52):6800-13.
  • Heath PT, Balfour GF, Tighe H, Verlander NQ, Lamagni TL, Efstratiou A; HPA GBS Working Group. Group B streptococcal disease in infants: a case control study. Arch Dis Child. 2009 Sep;94(9):674-80.
  • Ladhani S, Paul T Heath, Mary E Ramsay, Mary PE Slack, Elizabeth Kibwana, Andrew J Pollard, Robert Booy. Long-term immunological follow-up of children with Hib vaccine failure. Clin Infect Dis. 2009 Aug 1;49(3):372-80.
  • Ladhani, Shamez; Heath, Paul; Slack, Mary; McIntyre, Peter; Diez-Domingo, Javier; Campos Marqués, José; Dagan, Ron; Ramsay, Mary. Haemophilus influenzae serotype b conjugate vaccine failure in twelve countries with established national childhood immunisation programmes. Clin Microbiol Infect. 2010 Jul;16(7):948-54. Epub 2009 Nov 4.
  • Vergnano S, Embleton ND, Collinson A, Menson E, Bedford Russell AR, Heath PT. Missed opportunities for preventing GBS infections. Arch Dis Child Fetal Neonatal Ed. 2010;95(1):F72-3.
  • Cervicofacial nontuberculous mycobacterium lymphadenitis in children: is surgery always necessary? Harris RL, Modayil P, Adam J, Sharland M, Heath P, Planche T, Daya H. Int J Pediatr Otorhinolaryngol. 2009 Sep;73(9):1297-301
  • Jessica M. Bate, Soonie R. Patel, Julia Chisholm, Paul T. Heath. Immunisation practices of paediatric oncology and shared care oncology consultants: a United Kingdom survey. Pediatric blood & cancer 2010;54(7):941-6

  • Shamez Ladhani, Mary P.E. Slack, Paul T. Heath, Anne von Gottberg, Manosree Chandra, Mary E. Ramsay and EU-IBIS participants. Invasive Haemophilus influenzae disease in the post-vaccine era: data from European surveillance 1996-2006. Emerg Infect Dis. 2010 Mar;16(3):455-63.
  • Ladhani S, Heath PT, Aibara RJ, Ramsay ME, Slack MP, Hibberd ML,Pollard AJ,Moxon ER,Booy R. Long-term complications and risk of other serious infections following invasive Haemophilus influenzae serotype b disease in vaccinated children. Vaccine. 2010 Mar 2;28(10):2195-200. Epub 2010 Jan 5.
  • Baba Inusa, Nimze Gadong, Michele Afif, Sarah Arnott, Paul Heath, Grant Marais, Helen Payne, Paula Robertson, Olu Wilky, Mark Zuckerman, David C Rees. Pandemic influenza A (H1N1) virus infections in children with sickle cell disease. Blood. 2010 Mar 18;115(11):2329-30.
  • Shamez Ladhani, Ray Borrow, Paul T Heath, Mary E Ramsay, Robert Booy. Low serum serotype-specific pneumococcal antibody concentrations in young children with Haemophilus influenzae serotype b (Hib) vaccine failure. Vaccine. 2010 Jun 17;28(28):4440-4.
  • Soonie R.Patel, Jessica Bate, Ray Borrow, Paul T.Heath. Serotype-specific Pneumococcal Antibody Concentrations In Children Treated For Acute Leukaemia. Arch Dis Child. 2010 Aug 12.
  • Empirical treatment of septic neonates- are the current guidelines adequate? B Muller-Pebody, AP Johnson, PT Heath, RE Gilbert, KL Henderson, M Sharland. Arch Dis Child Fetal Neonatal Ed. 2011 Jan;96(1):F4-8.
  • Neonatal infections in England: the NeonIN network. Stefania Vergnano, Esse Menson, Nigel Kennea, Nick D Embleton, Alison Ruth Bedford Russell, Timothy Watts, Mike J Robinson, Andrew Collinson, and Paul T Heath. Arch Dis Child Fetal Neonatal Ed. 2011 Jan;96(1):F9-F14.
  • Risk factors for late onset Gram-negative Infections: A Case Control Study
    Srabani Samanta, Kate Farrer, Aodhan Breathnach, and Paul T Heath. Arch Dis Child Fetal Neonatal Ed. 2011 Jan;96(1):F15-8.
  • Open Label, Randomized, Parallel-Group, Multi-Centre Study to Evaluate the Safety, and Immunogenicity of an AS03B /oil-in-water emulsion-adjuvanted split-virion vs. non-adjuvanted whole virion H1N1 influenza vaccine in UK children 6 months to 12 years of age. Claire Waddington, Woolf Walker, Clarisa Oeser, Amanda Reiner, Tessa John, Suzanne Wilkins, Michelle Casey, Polly Eccleston, Ruth Allen, Ifeanyichukwu Okike, Shamez Ladhani, Elizabeth Sheasby, Katja Hoschler, Nick Andrews, Pauline Waight, Andrew Collinson, Paul T Heath, Adam Finn, Saul Faust, Matthew David Snape, Elizabeth Miller, and Andrew J Pollard. BMJ. 2010 May 27;340:c2649.
  • Ladhani Shamez N; Davila Sonia; Hibberd Martin L; Heath Paul T; Ramsay Mary E; Slack Mary P E; Pollard Andrew J; Booy Robert. Association between single-nucleotide polymorphisms in Mal/TIRAP and interleukin-10 genes and susceptibility to invasive haemophilus influenzae serotype b infection in immunized children. Clinical infectious Diseases 2010;51(7):761-7.
  • X-linked lymphoproliferative disease due to SAP/SH2D1A deficiency: a multicenter study on the manifestations, management, and outcome of the disease. Claire A Booth, Kimberly C Gilmour, Paul Veys, Andrew R Gennery, Mary A Slatter, Helen Chapel, Paul Heath, Colin G Steward, Owen Smith, Anna O'Meara, Hilary Kerrigan, Nizar Mahlaoui, Marina Cavazzana-Calvo, Alain Fischer, Despina Moshous, Stephane Blanche, Jana Pachlopnik-Schmid, Sylvain Latour, Genevieve de Saint Basile, Michael Albert, Gundula Notheis, Nikolaus Rieber, Brigitte Strahm, Henrike Ritterbusch, Arjan Lankester, Nico G Hartwig, Isabelle Meyts, Alessandro Plebani, Annarosa Soresina, Andrea Finocchi, Claudio Pignata, Emilia Cirillo, Sonia Bonanomi, Christina Peters, Krzysztof Kalwak, Srdjan Pasic, Petr Sedlacek, Janez Jazbec, Hirokazu Kanegane, Kim E Nichols, I Celine Hanson, Neena Kapoor, Elie Haddad, Morton J Cowan, Sharon Choo, Joanne Smart, Peter D Arkwright, and Hubert B Gaspar. Blood. 2011 Jan 6;117(1):53-62.
  • Waddington C, Andrews N, Hoschler K, Walker W, Oeser C, Reiner A, John T, Wilkins S, Casey M, Eccleston P, Allen R, Okike I, Ladhani S, Sheasby E, Waight P, Collinson A, Heath P, Finn A, Faust S, Snape M, Miller E, Pollard A. Open-label, randomised, parallel-group, multicentre study to evaluate the safety, tolerability and immunogenicity of an AS03(B)/oil-in-water emulsion-adjuvanted (AS03(B)) split-virion versus non-adjuvanted whole-virion H1N1 influenza vaccine in UK children 6 months to 12 years of age. Health Technol Assess. 2010 Oct;14(46):1-130
  • Matthew D. Snape, Chaam L. Klinger, Elvis D. Daniels,Tessa M. John, Helen Layton, Llinos Rollinson, Sarah Pestridge, Sandra Dymond, Eva Galiza, Susan Tansey, Daniel A. Scott, Sherryl A. Baker, Thomas R. Jones, Ly-Mee Yu, William C. Gruber, Emilio A. Emini, Saul N. Faust, Adam Finn, Paul T. Heath, Andrew J. Pollard. Immunogenicity and Reactogenicity of a 13-Valent pneumococcal Conjugate Vaccine Administered at 2, 4, and 12 Months of Age. A Double-blind Randomized Active-controlled Trial. Pediatr Infect Dis J. 2010 Dec;29(12):e80-90.
  • Bate J, Yung CF, Hoschler K, Sheasby L, Morden J, Taj M, Heath PT, Miller E. Immunogenicity of pandemic (H1N1) 2009 vaccine in children with cancer in the United Kingdom. Clin Infect Dis. 2010 Dec 15;51(12):e95-104.
  • Depani SJ, Ladhani S, Heath PT, Lamagni TL, Johnson AP, Pebody RG, Ramsay ME, Sharland M. The Contribution of Infections to Neonatal Deaths in England and Wales. Pediatr Infect Dis J. 2011 Feb 11. [Epub ahead of print]
  • Stefania Vergnano, Esse Menson, Zoe Smith, Nigel Kennea, Nick D Embleton, Paul Clarke, Timothy Watts, Paul T Heath. Characteristics of invasive Staphylococcus aureus in English neonatal units. Pediatr Infect Dis J. 2011 Oct;30(10):850-4.
  • Kadambari S, Heath PT, Sharland M, Lewis S, Nicholls, A, Turner MA. Variation in gentamicin and vancomycin dosage and monitoring in UK neonatal units. Journal of Antimicrobial Chemotherapy 2011 Nov;66(11):2647-50
  • Ifeanyichukwu O. Okike, Chee Yung, Shamez Ladhani, Clarissa Oeser, Aisleen Bennett, Katja Doerholt, Sharon Storey, Sheila folgarighy, Nigel Butter, Katja Hoschler, Liz Sheasby, Paul T. Heath, Elizabeth Miller. The immunogenicity of a novel A (H1N1) vaccine in HIV-infected children. Vaccine. 2011 Sep 2;29(38):6636-40
  • Bate J, Chisholm J, Heath PT, Breuer J, Skinner R, Manley S, Patel S, Wheatley K, Ramsay M, Kearns PR, Hambleton S. PEPtalk: postexposure prophylaxis against varicella in children with cancer. Arch Dis Child. 2011 Sep;96(9)
  • Irja Lutsar, Ursula MT Trafojer, Paul T Heath, Tuuli Metsvaht, Joseph Standing, Susanna Esposito, Vincent Meiffredi de Cabre, Clarissa Oeser and Jean-Pierre Aboulker. Meropenem vs standard of care for treatment of late onset sepsis in children of less than 90 days of age: study protocol for a randomised controlled trial. Trials. 2011 Sep 30;12:215
  • Shamez Ladhani, Clarissa Oeser, Joanne Sheldon, Mary Ramsay, Robert Booy, Paul T. Heath. Immunoglobulin Deficiency in children with Hib vaccine failure. Vaccine. 2011 Nov 15;29(49):9137-40
  • Predictors of immune response and reactogenicity to AS03B-adjuvanted split virion and non-adjuvanted whole virion H1N1 (2009) pandemic influenza vaccines. Andrews NJ, Walker WT, Finn A, Heath PT, Collinson AC, Pollard AJ, Snape MD, Faust SN, Waight PA, Hoschler K, Sheasby L, Waddington C, Kerridge S, Chalk J, Reiner A, John T, Fletcher M, Allen R, Fineman N, Wilkins S, Casey M, Michaelis L, Oeser C, Okike I, Ladhani S, Miller E. Vaccine. 2011 Oct 19;29(45):7913-9. Epub 2011 Aug 27.
  • Immunization status of children with HIV: failure to protect a vulnerable population. Zinna S, Bamford A, Cunnington A, Kampmann B, Lyall E, Menson E, Heath P. HIV Med. 2011 Aug;12(7):447-8
  • KM Edmond, C Kortsalioudaki, S Scott, S Schrag, A Zaidi, S Cousens, PT Heath. Group B streptococcal disease in infants under 3 months; systematic review and meta-analysis. Lancet. 2012;379(9815):547-56.
  • Woolf T. Walker, Philip de Whalley, Nick Andrews, Clarissa Oeser, Michelle Casey, Louise Michaelis, Katja Hoschler, Caroline Harrill, Phoebe Moulsdale, Ben Thompson, Claire Jones, Jem Chalk, Simon Kerridge, Tessa M. John, Ifeanyichukwu Okike, Shamez Ladhani, Richard Tomlinson, Paul T. Heath, Elizabeth Miller, Saul N. Faust, Matthew D Snape, Adam Finn , Andrew J. Pollard. H1N1 antibody persistence one year after immunisation with an adjuvanted or whole virion pandemic vaccine and immunogenicity and reactogenicity of subsequent seasonal influenza vaccine: a multi-centre follow-on study. Clin Infect Dis. 2012 Mar 1;54(5):661-9
  • Alice E Martin, Stefania Vergnano, Mark Anthony, Alison Bedford Russell, Nigel Kennea, Timothy Watts, Nick Embleton, Paul T Heath, Andrew Collinson. Early Onset Group B Streptococcus – Guidelines Review. Journal of Infection Prevention May 2012 vol. 13 no. 3 75-78.
  • Claudia Turner, Paul Turner, Linda Po, Naw Maner, Aruni De Zoysa, Baharak Afshar, Androulla Efstratiou, Paul T Heath and François Nosten. Group B Streptococcal carriage, serotype distribution and antibiotic susceptibilities in pregnant women at the time of delivery in a refugee population on the Thai - Myanmar border. BMC Infect Dis. 2012 Feb 8;12:34
  • Erlewyn-Lajeunesse M, Hunt LP, Heath PT, Finn A. Anaphylaxis as an adverse event following immunisation in the UK and Ireland. Arch Dis Child. 2012 Jun;97(6):487-90
  • de Whalley P, Walker W, Snape MD, Oeser C, Casey M, Moulsdale P, Harrill C, Andrews N, Hoschler K, Thompson B, Jones C, Chalk J, Kerridge S, Tomlinson R, Heath PT, Finn A, Faust S, Miller E, Pollard AJ. A 1-year follow-on study from a randomised, head-to-head, multicentre, open-label study of two pandemic influenza vaccines in children. Health Technol Assess. 2011 Dec;15(45):v-vi, xi-xiii, 1-128.
  • Neonatal sepsis - many blood samples, few positive cultures: implications for improving antibiotic prescribing. Blackburn RM, Muller-Pebody B, Planche T, Johnson A, Hopkins S, Sharland M, Kennea N, Heath PT. Arch Dis Child Fetal Neonatal Ed. 2012 Nov;97(6):F487-8
  • Oeser C, Lamagni T, Heath PT, Sharland M, Ladhani S. The epidemiology of neonatal and pediatric candidemia in England and wales, 2000-2009. Pediatr Infect Dis J. 2013 Jan;32(1):23-6
  • Khatami A, Snape MD, Ohene-Kena B, Young K, Oeser C, Michaelis LJ, Macleod E, Smee H, Van Der Meeren O, Leyssen M, Caubet M, Yu L-M, Heath PT, Faust SN, Finn A, Pollard AJ. Phase II study of a three-dose primary vaccination course of DTPa-IPV/Hib-MenC-TT followed by a 12-month Hib-MenC-TT booster in healthy infants. Pediatr Infect Dis J. 2013;32(6):675-681.
  • The changing antibiotic susceptibility of bloodstream infections in the first month of life: informing antibiotic policies for early- and late-onset neonatal sepsis. Blackburn RM, Verlander NQ, Heath PT, Muller-Pebody B. Epidemiol Infect. 2013 Jul 11:1-9).
  • The United Kingdom Primary Immune Deficiency (UKPID) Registry: Report of the first 4 years' activity 2008-2012. Edgar JD, Buckland M, Guzman D, Conlon NP, Knerr V, Bangs C, Reiser V, Panahloo Z, Workman S, Slatter M, Gennery AR, Davies EG, Allwood Z, Arkwright PD, Helbert M, Longhurst HJ, Grigoriadou S, Devlin LA, Huissoon A, Krishna MT, Hackett S, Kumararatne DS, Condliffe AM, Baxendale H, Henderson K, Bethune C, Symons C, Wood P, Ford K, Patel S, Jain R, Jolles S, El-Shanawany T, Alachkar H, Herwadkar A, Sargur R, Shrimpton A, Hayman G, Abuzakouk M, Spickett G, Darroch CJ, Paulus S, Marshall SE, McDermott EM, Heath PT, Herriot R, Noorani S, Turner M, Khan S, Grimbacher B. Clin Exp Immunol. 2013 Jul 11.
  • Trends in paediatric nosocomial bacteraemia in a London tertiary hospital. Pérerz Lopéz A, Ladhani SN, Breathnach A, Planche T, Heath PT, Sharland M. Acta Paediatr. 2013 Jul 9.
  • A three year descriptive study of early onset neonatal sepsis in a refugee population on the Thailand Myanmar border. Turner C, Turner P, Hoogenboom G, Aye Mya Thein N, McGready R, Phakaudom K, De Zoysa A, Efstratiou A, Heath PT, Nosten F. BMC Infect Dis. 2013 Dec 21;13:601.
  • Attitudes towards vaccination against group B streptococcus in pregnancy. McQuaid F, Jones C, Stevens Z, Plumb J, Hughes R, Bedford H, Heath PT, Snape MD. Arch Dis Child. 2013 Dec 19
  • Systematic Review of Antibiotic Resistance Rates Among Gram-Negative Bacteria in Children With Sepsis in Resource-Limited Countries. Le Doare K, Bielicki J, Heath PT, Sharland M. J Pediatric Infect Dis Soc. 2015 Mar;4(1):11-20.
  • Oeser, Clarissa; Vergnano, Stefania; Naidoo, Ronelle; Anthony, Mark; Chang, John; Chow, Peter; Clarke, Paul; Embleton, Nick; Kennea, Nigel; Pattnayak, Santosh; Reichert, Bernd; Scorrer, Timothy; Tiron, Irina; Watts, Timothy; Sharland, Michael; Heath, Paul. Neonatal Invasive Fungal Infection in England 2004-2010. Clin Microbiol Infect. 2014 Sep;20(9):936-41.
  • Irja Lutsar, Corine Chazallon, Francesca Ippolita Calo Carducci, Ursula Trafojer, Ben Abdelkader, Vincent Meiffredy de Cabre, SusannaEsposito, Carlo Giaquinto, Paul T Heath, Mari-Liis Ilmoja, Aspasia Katragkou, Carine Lascoux, Tuuli Metsvaht, George Mitsiakos, Emmanuelle Netzer, Lorenza Pugni, Emmanuel Roilides, Yacine Saidi, Kosmas Sarafidis, Mike Sharland, Vytautas Usonis and Jean-Pierre Aboulker. Current management of late onset neonatal bacterial sepsis in five European countries. European Journal of Pediatrics 2014 (in press)
  • Okike IO, Ribeiro S, Ramsay ME, Heath PT, Sharland M, Ladhani SN. Trends in bacterial, mycobacterial, and fungal meningitis in England and Wales 2004-11: an observational study. Lancet Infect Dis. 2014 Apr;14(4):301-7.
  • Pneumococcal Serotype-Specific Antibodies Persist through Early Childhood after Infant Immunization: Follow-Up from a Randomized Controlled Trial. Trück J, Snape MD, Tatangeli F, Voysey M, Yu LM, Faust SN, Heath PT, Finn A, Pollard AJ. PLoS One. 2014 Mar 11;9(3):e91413
  • Soonie R. Patel, Jessica Bate, Peter A.C. Maple, Kevin Brown, Judith Breuer, Paul T. Heath. Varicella Zoster Immune Status in Children Treated for Acute Leukaemia. Pediatr Blood Cancer. 2014 Nov;61(11):2077-9.
  • R.C. Read, D. Baxter, D.R. Chadwick, S.N. Faust, A. Finn, S. Gordon, P.T. Heath, D.J.M Lewis, A.J. Pollard, D.P.J. Turner, R. Bazaz, T. Ganguli, T. Havelock, K.R. Neal, I. Okike, B. Morales-Aza, K. Patel, M.D. Snape, J. Williams, S. Gilchrist, S.J. Gray, M.C.J. Maiden, D. Toneatto, H. Wang , M. McCarthy, P.M. Dull, R. Borrow. Impact of a quadrivalent meningococcal ACWY glycoconjugate or a serogroup B meningococcal vaccine on meningococcal carriage: an observer-blind, phase 3 randomised clinical trial. Lancet. 2014 Dec 13;384(9960):2123-31.
  • Kadambari S, Okike I, Ribeiro S, Ramsay ME, Heath PT, Sharland M, Ladhani SN. Seven-fold increase in viral meningo-encephalitis reports in England and Wales during 2004-2013. J Infect. 2014 Oct;69(4):326-32.
  • Ifeanyichukwu O. Okike, Alan P. Johnson, Katherine L. Henderson, Ruth M. Blackburn, Berit Muller-Pebody, Shamez N Ladhani, Mark Anthony, Nelly Ninis, Paul T. Heath and the neoMen study group. Incidence, Aetiology and Outcome of Bacterial Meningitis in Infants aged <90 days in the United Kingdom and Republic of Ireland: prospective, enhanced, national population-based surveillance. Clin Infect Dis. 2014 Nov 15;59(10):e150-7.
  • Payne H, Judd A, Donegan K, Okike IO, Ladhani S, Doerholt K, Heath PT. Incidence of pneumococcal and varicella disease in HIV-infected children and adolescents in the UK and Ireland, 1996-2011. Pediatr Infect Dis J. 2015 Feb;34(2):149-54
  • Kadambari S, Botgros A, Clarke P, Vergnano S, Anthony M, Chang J, Collinson A, Embleton N, Kennea N, Settle P, Heath PT, Menson EN on behalf of the neonIN neonatal infection surveillance network. Characterising the burden of invasive Pseudomonas infection on neonatal units in the UK between 2005-2011. J Hosp Infect. 2014 Oct;88(2):109-12.
  • Manish Sadarangani, Louise Willis, Seilesh Kadambari, Stuart Gormley, Zoe Young, Rebecca Beckley, Katherine Gantlett, Katharine Orf, Sarah Blakey, Natalie G Martin, Dominic F Kelly, Paul T Heath, Simon Nadel, Andrew J Pollard. Childhood meningitis in the conjugate vaccine era: prospective cohort study. Arch Dis Child. 2015 Mar;100(3):292-4.
  • Vergnano S, Kadambari S, Whalley K, Menson E, Martinez-Alier N, Cooper M, Heath PT, Lyall H, Characteristics and outcomes of Human Parechovirus Infection in infants (2008-2012) European Journal of Pediatrics (in press).
  • M A Iro, A Khatami, A S J Marshall, D Pace, M Voysey, J McKenna, D Campbell, S Attard-Montalto, A Finn, C White, S N Faust, A Kent, P T Heath, E MacLeod, E Stanford, H Findlow, R Almond, X Bai, R Borrow, M D Snape, A J Pollard. Immunological effect of sequential administration of Haemophilus influenzae type b and pneumococcal conjugate vaccines in the routine infant immunisation schedule in the same limb versus alternating limbs: an open-label randomized controlled trial. Lancet Infect Dis. 2015 Feb;15(2):172-80.
  • Jenny Herbert, Stephen Thomas, Charlotte Brookes, Claudia Turner, Paul Turner, Francois Nosten, Kirsty LeDoare, Michael Hudson, Paul Heath, Andrew Gorringe and Stephen Taylor. Antibody-mediated complement C3b/iC3b binding to Group B Streptococcus in paired mother and baby serum samples in a refugee population on the Thailand-Myanmar border. Clin Vaccine Immunol. 2015 Mar;22(3):319-26
  • Meningococcal carriage in adolescents in the United Kingdom to inform timing of an adolescent vaccination strategy. Jeppesen CA, Snape MD, Robinson H, Gossger N, John TM, Voysey M, Ladhani S, Okike IO, Oeser C, Kent A, Oliver J, Taylor P, Morales-Aza B, Clarke SC, Casey M, Martins F, Kitchin NR, Anderson AS, Jones H, Jansen KU, Eiden J, Pedneault L, Heath PT, Finn A, Faust SN, Pollard AJ. J Infect. 2015 Jul;71(1):43-52
  • Anti-Group B Streptococcus antibody in infants born to mothers with human immunodeficiency virus (HIV) infection. Le Doare K, Allen L, Kampmann B, Heath PT, Taylor S, Hesseling AC, Gorringe A, Jones CE. Vaccine. 2015 Jan 29;33(5):621-7
  • Targeted empiric antibiotic therapy for children with non-oncological comorbidities and community-onset invasive bacterial infections. Wells R, Le Doare K, Sharland M, Heath P, Ladhani SN; CABIN Network. J Infect. 2015 Sep;71(3):294-301.
  • Measles Reimmunization May Not Be Effective in Protecting HIV-Infected Children. Rowson K, Tan A, Donaghy S, Doerholt K, Heath P, Riordan A. Pediatr Infect Dis J. 2015 May;34(5):552.
  • Immunogenicity of reduced dose priming schedules of serogroup C meningococcal conjugate vaccine followed by booster at 12 months in infants: open label randomised controlled trial. Pace D, Khatami A, McKenna J, Campbell D, Attard-Montalto S, Birks J, Voysey M, White C, Finn A, Macloed E, Faust SN, Kent AL, Heath PT, Borrow R, Snape MD, Pollard AJ. BMJ. 2015 Apr 1
  • 13-valent pneumococcal conjugate vaccine (PCV13) is immunogenic and safe in children 6-17 years of age with sickle cell disease previously vaccinated with 23-valent pneumococcal polysaccharide vaccine (PPSV23): Results of a phase 3 study. De Montalembert M, Abboud MR, Fiquet A, Inati A, Lebensburger JD, Kaddah N, Mokhtar G, Piga A, Halasa N, Inusa B, Rees DC, Heath PT, Telfer P, Driscoll C, Al Hajjar S, Tozzi A, Jiang Q, Emini EA, Gruber WC, Gurtman A, Scott DA. Pediatr Blood Cancer. 2015 Aug;62(8):1427-36.
  • Antibody Responses After Primary Immunization in Infants Born to Women Receiving a Pertussis-containing Vaccine During Pregnancy: Single Arm Observational Study With a Historical Comparator. Ladhani SN, Andrews NJ, Southern J, Jones CE, Amirthalingam G, Waight PA, England A, Matheson M, Bai X, Findlow H, Burbidge P, Thalasselis V, Hallis B, Goldblatt D, Borrow R, Heath PT, Miller E. Clin Infect Dis. 2015 Dec 1;61(11):1637-44.
  • Placental transfer of anti-Group B Streptococcus IgG antibody subclasses from HIV-infected and uninfected women to their uninfected infants. Kirsty Le Doare, Stephen Taylor, Lauren Allen, A. Gorringe, P.T. Heath, B. Kampmann, Anneke C. HESSELING, Christine Elizabeth Jones. AIDS 2015 (in press).
  • The current and future roles of neonatal infection surveillance programmes in combating antimicrobial resistance. Cailes B, Vergnano S, Kortsalioudaki C, Heath P, Sharland M. Early Hum Dev. 2015 Nov;91(11):613-8.
  • Safety of live attenuated influenza vaccine in atopic children with egg allergy. Turner PJ, Southern J, Andrews NJ, Miller E, Erlewyn-Lajeunesse M; SNIFFLE Study Investigators. J Allergy Clin Immunol. 2015 Aug;136(2):376-81
  • Factors affecting the causality assessment of adverse events following immunisation in paediatric clinical trials: An online survey. Voysey M, Tavana R, Farooq Y, Heath PT, Bonhoeffer J, Snape MD. Vaccine. 2015 Dec 16;33(51):7203-10
  • Neonatal infection: a major burden with minimal funding. Seale AC, Head MG, Fitchett EJ, Vergnano S, Saha SK, Heath PT, Sharland M, Lawn JE; SPRING. Lancet Glob Health. 2015 Nov;3(11):e669-70
  • Safety of live attenuated influenza vaccine in young people with egg allergy: multicentre prospective cohort study. Turner PJ, Southern J, Andrews NJ, Miller E, Erlewyn-Lajeunesse M; SNIFFLE-2 Study Investigators. BMJ. 2015 Dec 8;351:h6291.
  • Expanding the phenotype of TRNT1 related immunodeficiency to include childhood cataract and inner retinal dysfunction. Sarah Hull; Aeesha NJ Malik; Gavin Arno; Donna S Mackay; Vincent Plagnol; Michel Michaelides; Sahar Mansour; Assunta Albanese; Katrina Tatton Brown; Graham E Holder; Andrew R Webster; Paul T Heath; Anthony T Moore. JAMA Ophthalmology 2015 (in press).
  • Neonatal gram-negative infections, antibiotic susceptibility and clinical outcome: an observational study. Alison Kent, Christina Kortsalioudaki, Irene M Monahan, Julia Bielicki, Timothy D Planche, Paul T Heath, Mike Sharland. Arch Dis Child Fetal Neonatal Ed. 2016 Mar 7.
  • Lymphocyte subpopulations in premature infants: An observational study. Kent Alison, Scorrer Tim, Pollard Andrew, Snape Matthew D, Clarke Paul, Few Karen, Menson Esse, Varghese Anu, Hughes Stephen, Ladhani Shamez N, Heath Paul T. Arch Dis Child Fetal Neonatal Ed. 2016 Apr 13
  • Factors influencing women’s attitudes towards antenatal vaccines, Group B streptococcus and clinical trial participation in pregnancy: An on-line survey. BMJ Open. 2016 Apr 20;6(4):e010790.
  • Lack of evidence for the efficacy of enhanced surveillance compared to other specific interventions to control neonatal healthcare-associated infection outbreaks. Birt J, Le Doare K, Kortsalioudaki C, Lawn J, Heath PT, Sharland M. Trans R Soc Trop Med Hyg. 2016 Feb;110(2):98-106
  • Risk factors for Group B Streptococcus colonisation and disease in Gambian women and their infants. Le Doare K, Jarju S, Darboe S, Warburton F, Gorringe A, Heath PT, Kampmann B. J Infect. 2016 Mar;72(3):283-94
  • Schedules for Pneumococcal Vaccination of Preterm Infants: An RCT. Kent A, Ladhani SN, Andrews N, Scorrer T, Pollard A, Clarke P, Hughes S, Heal C, Menson E, Chang J, Satodia P, Collinson A, Pritchard N, Faust S, Goldblatt D, Miller E, Heath PT on behalf of the PUNS study group. Pediatrics. 2016 Sep;138(3). pii: e20153945
  • Pertussis antibody concentrations in infants born prematurely to mothers vaccinated in pregnancy. Kent A, Ladhani SN, Andrews NJ, Matheson M, England A, Miller E, Heath PT; PUNS study group. Pediatrics. 2016 Jul;138(1)
  • Development and evaluation of a gentamicin pharmacokinetic model that facilitates opportunistic gentamicin therapeutic drug monitoring in neonates and infants. Germovsek E, Kent A, Metsvaht T, Lutsar I, Klein N, Turner MA, Sharland M, Nielsen EI, Heath PT, Standing JF; neoGent collaboration. Antimicrob Agents Chemother. 2016 Jun 6.
  • Density Distribution of Pharyngeal Carriage of Meningococcus in Healthy Young Adults: New Approaches to Studying the Epidemiology of Colonization and Vaccine Indirect Effects. Finn A, Morales-Aza B, Sikora P, Giles J, Lethem R, Marlais M, Thors V, Pollard AJ, Faust S, Heath P, Vipond I, Ferreira M, Muir P, Januário L, Rodrigues F. Pediatr Infect Dis J. 2016 May 25
  • Neonatal infections: Case definition and guidelines for data collection, analysis, and presentation of immunisation safety data. Vergnano S, Buttery J, Cailes B, Chandrasekaran R, Chiappini E, Clark E, Cutland C, de Andrade SD, Esteves-Jaramillo A, Guinazu JR, Jones C, Kampmann B, King J, Kochhar S, Macdonald N, Mangili A, de Menezes Martins R, Muñoz CV, Padula M, Muñoz FM, Oleske J, Sanicas M, Schlaudecker E, Spiegel H, Subelj M, Sukumaran L, Tagbo BN, Top KA, Tran D, Heath PT; Brighton Collaboration Neonatal Infections Working Group. Vaccine. 2016 Dec 1;34(49):6038-6046
  • Guideline for collection, analysis and presentation of safety data in clinical trials of vaccines in pregnant women. Jones CE, Munoz FM, Spiegel HM, Heininger U, Zuber PL, Edwards KM, Lambach P, Neels P, Kohl KS, Gidudu J, Hirschfeld S, Oleske JM, Khuri-Bulos N, Bauwens J, Eckert LO, Kochhar S, Bonhoeffer J, Heath PT; Brighton Collaboration Immunization in Pregnancy Working Group. Vaccine. 2016 Dec 1;34(49):5998-6006
  • Persistence of Bactericidal Antibodies After Infant Serogroup B Meningococcal Immunization and Booster Dose Response at 12, 18 or 24 Months of Age. Snape MD, Voysey M, Finn A, Bona G, Esposito S, Principi N, Diez-Domingo J, Sokal E, Kieninger D, Prymula R, Dull PM, Kohl I, Barone M, Wang H, Toneatto D, Pollard AJ; European MenB Vaccine Study Group. Pediatr Infect Dis J. 2016 Apr;35(4):e113-23
  • Global alignment of immunization safety assessment in pregnancy - The GAIA project. Bonhoeffer J, Kochhar S, Hirschfeld S, Heath PT, Jones CE, Bauwens J, Honrado Á, Heininger U, Muñoz FM, Eckert L, Steinhoff M, Black S, Padula M, Sturkenboom M, Buttery J, Pless R, Zuber P; GAIA project participants. Vaccine. 2016 Dec 1;34(49):5993-5997
  • Strengthening the Reporting of Observational Studies in Epidemiology for Newborn Infection (STROBE-NI): an extension of the STROBE statement for neonatal infection research. Fitchett EJ, Seale AC, Vergnano S, Sharland M, Heath PT, Saha SK, Agarwal R, Ayede AI, Bhutta ZA, Black R, Bojang K, Campbell H, Cousens S, Darmstadt GL, Madhi SA, Meulen AS, Modi N, Patterson J, Qazi S, Schrag SJ, Stoll BJ, Wall SN, Wammanda RD, Lawn JE; SPRING (Strengthening Publications Reporting Infection in Newborns Globally) Group. Lancet Infect Dis. 2016 Oct;16(10):e202-13.
  • Guidance for the collection of case report form variables to assess safety in clinical trials of vaccines in pregnancy. Jones CE, Munoz FM, Kochhar S, Vergnano S, Cutland CL, Steinhoff M, Black S, Heininger U, Bonhoeffer J, Heath PT. Vaccine. 2016 Dec 1;34(49):6007-6014
  • Use of a booster dose of capsular group C meningococcal glycoconjugate vaccine to demonstrate immunologic memory in children primed with one or two vaccine doses in infancy. Pace D, Khatami A, Attard-Montalto S, Voysey M, Finn A, Faust SN, Heath PT, Borrow R, Snape MD, Pollard AJ. Vaccine. 2016 Dec 7;34(50):6350-6357
  • Persistence of bactericidal antibodies following booster vaccination with 4CMenB at 12, 18 or 24 months and immunogenicity of a fifth dose administered at 4 years of age-a phase 3 extension to a randomised controlled trial. Mildred A. Iro, Matthew D. Snape, Merryn Voysey, Sena Jawad, Adam Finn, Paul T. Heath, Gianni Bona, Susanna Esposito, Javier Diez-Domingo, Roman Prymula, Adefowope Odueyungbo, Daniela Toneatto, Peter Dull, Andrew J. Pollard, The European Men B Vaccine Study Group. Vaccine. 2017;35(2):395-402.
  • Neonatal listeriosis in the UK 2004-2014. Sapuan S, Kortsalioudaki C, Anthony M, Chang J, Embleton ND, Geethanath RM, Gray J, Greenough A, Lal MK, Luck S, Pattnayak S, Reynolds P, Russell AB, Scorrer T, Turner M, Heath PT, Vergnano S. J Infect. 2017 Mar;74(3):236-242.
  • Group B Streptococcus and Respiratory Syncytial Virus immunization during pregnancy: a landscape analysis. Paul T Heath; Fiona J Culley; Christine E. Jones; Beate Kampmann; Kirsty Le Doare; Marta C. Nunes; Manish Sadarangani; Zain Chaudhry; Carol J. Baker; Peter JM Openshaw. Lancet Infect Dis. 2017 Jul;17(7):e223-e234
  • Kirsty Le Doare, Amadou Faal, Mustapha Jaiteh, Francess Sarfo, Stephen Taylor, Fiona Warburton, Holly Humphries, Jessica Birt, Sheikh Jarju, Saffiatou Darboe, Edward Clarke, Martin Antonio, Ebenezer Foster-Nyarko, Paul T. Heath, Andrew Gorringe, Beate Kampmann. Association between functional antibody against Group B Streptococcus and maternal and infant colonization in a Gambian cohort. Vaccine. 2017 May 19;35(22):2970-2978.
  • Ifeanyichukwu O Okike, Shamez N Ladhani, Mark Anthony, Nelly Ninis, Paul Heath. Assessment of healthcare delivery in the early management of bacterial meningitis in UK young infants: An observational study. BMJ Open. 2017 Aug 21;7(8)
  • Maternal vaccination against pertussis: a systematic review of the recent literature. Gkentzi D, Katsakiori P, Marangos M, Hsia Y, Amirthalingam G, Heath PT, Ladhani S. Arch Dis Child Fetal Neonatal Ed. 2017 Sep;102(5):F456-F463.
  • The relationship between Gram-negative colonization and bloodstream infections in neonates: a systematic review and meta-analysis. Folgori L, Tersigni C, Hsia Y, Kortsalioudaki C, Heath P, Sharland M, Bielicki J. Clin Microbiol Infect. 2017 Aug 19. pii: S1198-743
  • Antimicrobial resistance in UK neonatal units: neonIN infection surveillance network. Cailes B, Kortsalioudaki C, Buttery J, Pattnayak S, Greenough A, Matthes J, Bedford Russell A, Kennea N, Heath PT; neonIN network. Arch Dis Child Fetal Neonatal Ed. 2017 Oct 26
  • Neonatal encephalopathy: Case definition & guidelines for data collection, analysis, and presentation of maternal immunisation safety data. Sell E, Munoz FM, Soe A, Wiznitzer M, Heath PT, Clarke ED, Spiegel H, Sawlwin D, Šubelj M, Tikhonov I, Mohammad K, Kochhar S; Brighton Collaboration Acute Neonatal Encephalopathy Working Group. Vaccine. 2017 Dec 4;35(48 Pt A):6501-6505.
  • Congenital microcephaly: Case definition & guidelines for data collection, analysis, and presentation of safety data after maternal immunisation. DeSilva M, Munoz FM, Sell E, Marshall H, Tse Kawai A, Kachikis A, Heath P, Klein NP, Oleske JM, Jehan F, Spiegel H, Nesin M, Tagbo BN, Shrestha A, Cutland CL, Eckert LO, Kochhar S, Bardají A; Brighton Collaboration Congenital Microcephaly Working Group. Vaccine. 2017 Dec 4;35(48 Pt A):6472-6482.
  • Congenital Cytomegalovirus: A European Expert Consensus Statement on Diagnosis and Management. Luck SE, Wieringa JW, Blázquez-Gamero D, Henneke P, Schuster K, Butler K, Capretti MG, Cilleruelo MJ, Curtis N, Garofoli F, Heath P, Iosifidis E, Klein N, Lombardi G, Lyall H, Nieminen T, Pajkrt D, Papaevangelou V, Posfay-Barbe K, Puhakka L, Roilides E, Rojo P, Saavedra-Lozano J, Shah T, Sharland M, Saxen H, Vossen ACTM; ESPID Congenital CMV Group Meeting, Leipzig 2015. Pediatr Infect Dis J. 2017 Dec;36(12):1205-1213.
  • Estimates of the Burden of Group B Streptococcal Disease Worldwide for Pregnant Women, Stillbirths, and Children. Seale AC, Bianchi-Jassir F, Russell NJ, Kohli-Lynch M, Tann CJ, Hall J, Madrid L, Blencowe H, Cousens S, Baker CJ, Bartlett L, Cutland C, Gravett MG, Heath PT, Ip M, Le Doare K, Madhi SA, Rubens CE, Saha SK, Schrag SJ, Sobanjo-Ter Meulen A, Vekemans J, Lawn JE. Clin Infect Dis. 2017 Nov 6;65(suppl_2):S200-S219.
  • Neurodevelopmental Impairment in Children After Group B Streptococcal Disease Worldwide: Systematic Review and Meta-analyses. Kohli-Lynch M, Russell NJ, Seale AC, Dangor Z, Tann CJ, Baker CJ, Bartlett L, Cutland C, Gravett MG, Heath PT, Ip M, Le Doare K, Madhi SA, Rubens CE, Saha SK, Schrag S, Sobanjo-Ter Meulen A, Vekemans J, O'Sullivan C, Nakwa F, Ben Hamouda H, Soua H, Giorgakoudi K, Ladhani S, Lamagni T, Rattue H, Trotter C, Lawn JE. Clin Infect Dis. 2017 Nov 6;65(suppl_2):S190-S199.
  • Neonatal Encephalopathy With Group B Streptococcal Disease Worldwide: Systematic Review, Investigator Group Datasets, and Meta-analysis. Tann CJ, Martinello KA, Sadoo S, Lawn JE, Seale AC, Vega-Poblete M, Russell NJ, Baker CJ, Bartlett L, Cutland C, Gravett MG, Ip M, Le Doare K, Madhi SA, Rubens CE, Saha SK, Schrag S, Sobanjo-Ter Meulen A, Vekemans J, Heath PT; GBS Neonatal Encephalopathy Investigator Group. Clin Infect Dis. 2017 Nov 6;65(suppl_2):S173-S189.
  • Preterm Birth Associated With Group B Streptococcus Maternal Colonization Worldwide: Systematic Review and Meta-analyses.Bianchi-Jassir F, Seale AC, Kohli-Lynch M, Lawn JE, Baker CJ, Bartlett L, Cutland C, Gravett MG, Heath PT, Ip M, Le Doare K, Madhi SA, Saha SK, Schrag S, Sobanjo-Ter Meulen A, Vekemans J, Rubens CE. Clin Infect Dis. 2017 Nov 6;65(suppl_2):S133-S142
  • Maternal Disease With Group B Streptococcus and Serotype Distribution Worldwide: Systematic Review and Meta-analyses. Hall J, Adams NH, Bartlett L, Seale AC, Lamagni T, Bianchi-Jassir F, Lawn JE, Baker CJ, Cutland C, Heath PT, Ip M, Le Doare K, Madhi SA, Rubens CE, Saha SK, Schrag S, Sobanjo-Ter Meulen A, Vekemans J, Gravett MG. Clin Infect Dis. 2017 Nov 6;65(suppl_2):S112-S124.
  • Maternal Colonization With Group B Streptococcus and Serotype Distribution Worldwide: Systematic Review and Meta-analyses.Russell NJ, Seale AC, O'Driscoll M, O'Sullivan C, Bianchi-Jassir F, Gonzalez-Guarin J, Lawn JE, Baker CJ, Bartlett L, Cutland C, Gravett MG, Heath PT, Le Doare K, Madhi SA, Rubens CE, Schrag S, Sobanjo-Ter Meulen A, Vekemans J, Saha SK, Ip M; GBS Maternal Colonization Investigator Group. Clin Infect Dis. 2017 Nov 6;65(suppl_2):S100-S111.
  • Infant Group B Streptococcal Disease Incidence and Serotypes Worldwide: Systematic Review and Meta-analyses. Madrid L, Seale AC, Kohli-Lynch M, Edmond KM, Lawn JE, Heath PT, Madhi SA, Baker CJ, Bartlett L, Cutland C, Gravett MG, Ip M, Le Doare K, Rubens CE, Saha SK, Sobanjo-Ter Meulen A, Vekemans J, Schrag S; Infant GBS Disease Investigator Group. Clin Infect Dis. 2017 Nov 6;65(suppl_2):S160-S172.
  • Risk of Early-Onset Neonatal Group B Streptococcal Disease With Maternal Colonization Worldwide: Systematic Review and Meta-analyses. Russell NJ, Seale AC, O'Sullivan C, Le Doare K, Heath PT, Lawn JE, Bartlett L, Cutland C, Gravett M, Ip M, Madhi SA, Rubens CE, Saha SK, Schrag S, Sobanjo-Ter Meulen A, Vekemans J, Baker CJ. Clin Infect Dis. 2017 Nov 6;65(suppl_2):S152-S159.
  • Intrapartum Antibiotic Chemoprophylaxis Policies for the Prevention of Group B Streptococcal Disease Worldwide: Systematic Review. Le Doare K, O'Driscoll M, Turner K, Seedat F, Russell NJ, Seale AC, Heath PT, Lawn JE, Baker CJ, Bartlett L, Cutland C, Gravett MG, Ip M, Madhi SA, Rubens CE, Saha SK, Schrag S, Sobanjo-Ter Meulen A, Vekemans J, Kampmann B; GBS Intrapartum Antibiotic Investigator Group. Clin Infect Dis. 2017 Nov 6;65(suppl_2):S143-S151.
  • Stillbirth With Group B Streptococcus Disease Worldwide: Systematic Review and Meta-analyses. Seale AC, Blencowe H, Bianchi-Jassir F, Embleton N, Bassat Q, Ordi J, Menéndez C, Cutland C, Briner C, Berkley JA, Lawn JE, Baker CJ, Bartlett L, Gravett MG, Heath PT, Ip M, Le Doare K, Rubens CE, Saha SK, Schrag S, Meulen AS, Vekemans J, Madhi SA. Clin Infect Dis. 2017 Nov 6;65(suppl_2):S125-S132.
  • Persistence of immunity after vaccination with a capsular group B meningococcal vaccine in 3 different toddler schedules.Sadarangani M, Sell T, Iro MA, Snape MD, Voysey M, Finn A, Heath PT, Bona G, Esposito S, Diez-Domingo J, Prymula R, Odueyungbo A, Toneatto D, Pollard AJ; European MenB Vaccine Study Group. CMAJ. 2017 Oct 16;189(41):E1276-E1285
  • Epidemiology of UK neonatal infections: the neonIN infection surveillance network. Cailes B, Kortsalioudaki C, Buttery J, Pattnayak S, Greenough A, Matthes J, Bedford Russell A, Kennea N, Heath PT; neonIN network. Arch Dis Child Fetal Neonatal Ed. 2017 Dec 5.
  • A Bivalent Meningococcal B Vaccine in Adolescents and Young Adults. Ostergaard L, Vesikari T, Absalon J, Beeslaar J, Ward BJ, Senders S, Eiden JJ, Jansen KU, Anderson AS, York LJ, Jones TR, Harris SL, O'Neill R, Radley D, Maansson R, Prégaldien JL, Ginis J, Staerke NB, Perez JL; B1971009 and B1971016 Trial Investigators. N Engl J Med. 2017 Dec 14;377(24):2349-2362
  • Antenatal vaccination against Group B streptococcus: attitudes of pregnant women and healthcare professionals in the UK towards participation in clinical trials and routine implementation. McQuaid F, Jones C, Stevens Z, Meddaugh G, O'Sullivan C, Donaldson B, Hughes R, Ford C, Finn A, Faust SN, Gbesemete D, Bedford H, Hughes S, Varghese AS, Heath PT, Snape MD. Acta Obstet Gynecol Scand. 2018 Mar;97(3):330-340
  • Clinical Characteristics and Risk Factors for Poor Outcome in Infants Less Than 90 Days of Age With Bacterial Meningitis in the United Kingdom and Ireland. Okike IO, Ladhani SN, Johnson AP, Henderson KL, Blackburn RM, Muller-Pebody B, Cafferkey M, Anthony M, Ninis N, Heath PT; neoMen Study Group.Pediatr Infect Dis J. 2018 Sep;37(9):837-843
  • Management of suspected paediatric meningitis: a multicentre prospective cohort study. Ramasamy R, Willis L, Kadambari S, Kelly DF, Heath PT, Nadel S, Pollard AJ, Sadarangani M. Arch Dis Child. 2018 Feb 7
  • Safety of meningococcal group B vaccination in hospitalised premature infants. Kent A, Beebeejaun K, Braccio S, Kadambari S, Clarke P, Heath PT, Ladhani S; National Neonatal Audit Network. Arch Dis Child Fetal Neonatal Ed. 2019 Mar;104(2):F171-F175
  • Plasma and CSF pharmacokinetics of meropenem in neonates and young infants: results from the NeoMero studies. Germovsek E, Lutsar I, Kipper K, Karlsson MO, Planche T, Chazallon C, Meyer L, Trafojer UMT, Metsvaht T, Fournier I, Sharland M, Heath P, Standing JF; NeoMero Consortium. J Antimicrob Chemother. 2018 Apr 19
  • PEPtalk2: results of a pilot randomised controlled trial to compare VZIG and aciclovir as postexposure prophylaxis (PEP) against chickenpox in children with cancer. Bate J, Baker S, Breuer J, Chisholm JC, Gray J, Hambleton S, Houlton A, Jit M, Lowis S, Makin G, O'Sullivan C, Patel SR, Phillips R, Ransinghe N, Ramsay ME, Skinner R, Wheatley K, Heath PT. Arch Dis Child. 2018 May 5
  • Epidemiology of infections and antimicrobial use in Greek Neonatal Units. Gkentzi D, Kortsalioudaki C, Cailes BC, Zaoutis T, Kopsidas J, Tsolia M, Spyridis N, Siahanidou S, Sarafidis K, Heath PT, Dimitriou G; Neonatal Infection Surveillance Network in Greece. Arch Dis Child Fetal Neonatal Ed. 2018 Jun 28
  • Cost-effectiveness analysis of maternal immunisation against group B Streptococcus (GBS) disease: A modelling study. Giorgakoudi K, O'Sullivan C, Heath PT, Ladhani S, Lamagni T, Ramsay M, Al-Janabi H, Trotter C. Vaccine. 2018 Oct 3.
  • Invasive pneumococcal disease in UK children under 1 year of age in the post-PCV13 era: what are the risks now? Kent A, Makwana A, Sheppard CL, Collins S, Fry NK, Heath PT, Ramsay M, Ladhani SN. Clin Infect Dis. 2019 Jun 18;69(1):84-90.
  • Prevention of vaccine-matched and mismatched influenza in children aged 6-35 months: a multinational randomised trial across five influenza seasons. Claeys C; Flu4VEC Study Group. Lancet Child Adolesc Health. 2018 May;2(5):338-349.
  • Group B streptococcal disease in UK and Irish infants younger than 90 days, 2014-15: a prospective surveillance study.O'Sullivan CP, Lamagni T, Patel D, Efstratiou A, Cunney R, Meehan M, Ladhani S, Reynolds AJ, Campbell R, Doherty L, Boyle M, Kapatai G, Chalker V, Lindsay D, Smith A, Davies E, Jones CE, Heath PT. Lancet Infect Dis. 2018 Nov 26
  • Epidemiology and healthcare factors associated with neonatal enterococcal infections. Wang J, Kortsalioudaki C, Heath PT, Buttery J, Clarke P, Gkentzi D, Anthony M, Tan K; neonIN network. Arch Dis Child Fetal Neonatal Ed. 2019 Sep;104(5):F480-F485
  • Determinants of Influenza and Pertussis Vaccination Uptake in Pregnancy: A Multi-Centre Questionnaire Study of Pregnant Women and Healthcare Professionals. Wilcox CR, Calvert A, Metz J, Kilich E, MacLeod R, Beadon K, Heath PT, Khalil A, Finn A, Snape MD, Vandrevala T, Nadarzynski T, Coleman MA, Jones CE. Pediatr Infect Dis J. 2019 Jun;38(6):625-630
  • Enteral lactoferrin supplementation for very preterm infants: a randomised placebo-controlled trial. ELFIN trial investigators group. Lancet. 2019 Jan 8. pii: S0140-6736(18)32221-9
  • Enteral lactoferrin to prevent infection for very preterm infants: the ELFIN RCT. Griffiths J, Jenkins P, Vargova M, Bowler U, Juszczak E, King A, Linsell L, Murray D, Partlett C, Patel M, Berrington J, Embleton N, Dorling J, Heath PT, McGuire W, Oddie S. Health Technol Assess. 2018 Dec;22(74):1-60.
  • Safety and efficacy of 2% chlorhexidine gluconate aqueous versus 2% chlorhexidine gluconate in 70% isopropyl alcohol for skin disinfection prior to percutaneous central venous catheter insertion in preterm neonates: the ARCTIC randomised-controlled feasibility trial protocol. Paul Clarke, Jean V Craig, John Wain, Catherine Tremlett, Louise Linsell, Ursula Bowler, Ed Juszczak, Paul T Heath. BMJ OPEN 2019 (in press)
  • Attitudes of Pregnant Women and Healthcare Professionals Toward Clinical Trials and Routine Implementation of Antenatal Vaccination Against Respiratory Syncytial Virus: A Multicenter Questionnaire Study. Wilcox CR, Calvert A, Metz J, Kilich E, MacLeod R, Beadon K, Heath PT, Khalil A, Finn A, Snape MD, Vandrevala T, Nadarzynski T, Coleman MA, Jones CE. Pediatr Infect Dis J. 2019 Sep;38(9):944-951
  • Global Divergence From World Health Organization Treatment Guidelines for Neonatal and Pediatric Sepsis. Jackson C, Hsia Y, Basmaci R, Bielicki J, Heath PT, Versporten A, Goossens H, Sharland M. Pediatr Infect Dis J. 2019 Aug 12
  • Clinical Presentation of Influenza in Children 6 to 35 Months of Age: Findings From a Randomized Clinical Trial of Inactivated Quadrivalent Influenza Vaccine. Danier J, Rivera L, Claeys C, Dbaibo G, Jain VK, Kosalaraksa P, Woo W, Yanni E, Zaman K, Acosta B, Amanullah A, Ariza M, Luisa Arroba Basanta M, Bavdekar A, Carmona A, Cousin L, Diaz A, Diez-Domingo J, Cagri Dinleyici E, Faust SN, Garcia-Sicilia J, Gomez-Go GD, Antionette Gonzales L, Hacimustafaoglu M, Hughes SM, Izu A, Jackowska T, Kant S, Lucero M, Mares Bermudez J, Martinón-Torres F, Montellano M, Prymula R, Puthanakit T, Ruzkova R, Sadowska-Krawczenko I, Soni J, Szymanski H, Ulied A, Schuind A, Innis BL; Flu4VEC Study Group. Pediatr Infect Dis J. 2019 Aug;38(8):866-87
  • Surveillance of congenital Zika syndrome in England and Wales: methods and results of laboratory, obstetric and paediatric surveillance. Oeser C, Aarons E, Heath PT, Johnson K, Khalil A, Knight M, Lynn RM, Morgan D, Pebody R. Epidemiol Infect. 2019 Sep 4;147:e262
  • UKMenCar4: A cross-sectional survey of asymptomatic meningococcal carriage amongst UK adolescents at a period of low invasive meningococcal disease incidence. Bratcher HB, Rodrigues CMC, Finn A, Wootton M, Cameron JC, Smith A, Heath P, Ladhani S, Snape MD, Pollard AJ, Cunningham R, Borrow R, Trotter C, Gray SJ, Maiden MCJ, MacLennan JM. Version 2. Wellcome Open Res. 2019 Oct 28 [revised 2019 Jan 1];4:118.
  • 13-valent Pneumococcal Conjugate Vaccine in children with acute lymphoblastic leukaemia: protective immunity can be achieved on completion of treatment. Bate J, Borrow R, Chisholm J, Clark S, Dixon E, Faust SN, Galanopoulou A, Goldblatt D, Heath PT, Maishman T, Mapstone S, Patel S, Williams AP, Gray JC. Clin Infect Dis. 2019 Oct 5
  • Towards understanding global patterns of antimicrobial use and resistance in neonatal sepsis: insights from the NeoAMR network. Li G, Bielicki JA, Ahmed ASMNU, Islam MS, Berezin EN, Gallacci CB, Guinsburg R, da Silva Figueiredo CE, Santarone Vieira R, Silva AR, Teixeira C, Turner P, Nhan L, Orrego J, Pérez PM, Qi L, Papaevangelou V, Triantafyllidou P, Iosifidis E, Roilides E, Sarafidis K, Jinka DR, Nayakanti RR, Kumar P, Gautam V, Prakash V, Seeralar A, Murki S, Kandraju H, Singh S, Kumar A, Lewis L, Pukayastha J, Nangia S, K N Y, Chaurasia S, Chellani H, Obaro S, Dramowski A, Bekker A, Whitelaw A, Thomas R, Velaphi SC, Ballot DE, Nana T, Reubenson G, Fredericks J, Anugulruengkitt S, Sirisub A, Wong P, Lochindarat S, Boonkasidecha S, Preedisripipat K, Cressey TR, Paopongsawan P, Lumbiganon P, Pongpanut D, Sukrakanchana PO, Musoke P, Olson L, Larsson M, Heath PT, Sharland M. Arch Dis Child. 2020 Jan;105(1):26-31
  • PCR for the detection of pathogens in neonatal early onset sepsis. Oeser C, Pond M, Butcher P, Bedford Russell A, Henneke P, Laing K, Planche T, Heath PT, Harris K. PLoS One. 2020 Jan 24;15(1):e0226817.
  • Quadrivalent Influenza Vaccine Prevents Illness and Reduces Healthcare Utilization Across Diverse Geographic Regions During Five Influenza Seasons: A Randomized Clinical Trial. Dbaibo G, Amanullah A, Claeys C, Izu A, Jain VK, Kosalaraksa P, Rivera L, Soni J, Yanni E, Zaman K, Acosta B, Ariza M, Arroba Basanta ML, Bavdekar A, Carmona A, Cousin L, Danier J, Diaz A, Diez-Domingo J, Dinleyici EC, Faust SN, Garcia-Sicilia J, Gomez-Go GD, Gonzales MLA, Hacimustafaoglu M, Hughes SM, Jackowska T, Kant S, Lucero M, Mares Bermudez J, Martinón-Torres F, Montellano M, Prymula R, Puthanakit T, Ruzkova R, Sadowska-Krawczenko I, Szymanski H, Ulied A, Woo W, Schuind A, Innis BL; Flu4VEC Study Group. Pediatr Infect Dis J. 2020 Jan;39(1):e1-e10.
  • Neonatal seizures: Case definition & guidelines for data collection, analysis, and presentation of immunization safety data. Pellegrin S, Munoz FM, Padula M, Heath PT, Meller L, Top K, Wilmshurst J, Wiznitzer M, Das MK, Hahn CD, Kucuku M, Oleske J, Vinayan KP, Yozawitz E, Aneja S, Bhat N, Boylan G, Sesay S, Shrestha A, Soul JS, Tagbo B, Joshi J, Soe A, Maltezou HC, Gidudu J, Kochhar S, Pressler RM; Brighton Collaboration Neonatal Seizures Working Group. Vaccine. 2019 Dec 10;37(52):7596-7609
  • Developing a serocorrelate of protection against invasive group B streptococcus disease in pregnant women: a feasibility study. Carreras-Abad C, Cochet M, Hall T, Ramkhelawon L, Khalil A, Peregrine E, Vinayakarao L, Sivarajan S, Hamid R, Planche T, Sheridan E, Winchester S, Plumb J, Djennad A, Andrews N, Le Doare K, Heath P. Health Technol Assess. 2019 Dec;23(67):1-40
  • Systematic review of carbapenem-resistant Enterobacteriaceae causing neonatal sepsis in China. Ding Y, Wang Y, Hsia Y, Sharland M, Heath PT. Ann Clin Microbiol Antimicrob. 2019 Nov 14;18(1):36.
  • Hospital clusters of invasive Group B Streptococcal disease: A systematic review. Collin SM, Lamb P, Jauneikaite E, Le Doare K, Creti R, Berardi A, Heath PT, Sriskandan S, Lamagni T. J Infect. 2019 Dec;79(6):521-527.
  • Understanding pregnant women's readiness to engage in risk-reducing measures to prevent infections during pregnancy. Vandrevala T, Barber V, Calvert A, Star C, Khalil A, Griffiths P, Heath PT, Jones CE. J Health Psychol. 2019 Nov 5
  • Meropenem vs standard of care for treatment of neonatal late onset sepsis (NeoMero1): a randomised controlled trial. Irja Lutsar, Corine Chazallon, Ursula Trafojer, Vincent Meiffredy de Cabre, Cinzia Auriti, Chiara Bertaina, Francesca Ippolita Calo Carducci, Fuat Emre Canpolat, Susanna Esposito, Isabelle Fournier, Maarja Hallik, Paul T. Heath, Mari-Liis Ilmoja, Elias Iosifidis, Jelena Kuznetsova, Laurence Meyer, Tuuli Metsvaht, George Mitsiakos, Zoi Dorothea Pana, Fabio Mosca, Lorenza Pugni, Emmanuel Roilides, Paolo Rossi, Kosmas Sarafidis, Laura Sanchez, Michael Sharland, Vytautas Usonis, Adilia Warris, Jean-Pierre Aboulker, Carlo Giaquinto, on behalf of NeoMero Consortium. PLOS ONE 2020 (in press).
  • Prevention of Acquisition of Cytomegalovirus Infection in Pregnancy Through Hygiene-based Behavioral Interventions: A Systematic Review and Gap Analysis. Barber V, Calvert A, Vandrevala T, Star C, Khalil A, Griffiths P, Heath PT, Jones CE. Pediatr Infect Dis J. 2020 Jun 3.
  • ISUOG Practice Guidelines: role of ultrasound in congenital infection. Khalil A, Sotiriadis A, Chaoui R, da Silva Costa F, D'Antonio F, Heath PT, Jones C, Malinger G, Odibo A, Prefumo F, Salomon LJ, Wood S, Ville Y.Ultrasound Obstet Gynecol. 2020 May 13.
  • An optimised dosing regimen versus a standard dosing regimen of vancomycin for the treatment of late onset sepsis due to Gram-positive microorganisms in neonates and infants aged less than 90 days (NeoVanc): study protocol for a randomised controlled trial. Hill LF, Turner MA, Lutsar I, Heath PT, Hardy P, Linsell L, Jacqz-Aigrain E, Roilides E, Sharland M; NeoVanc Consortium.Trials. 2020 Apr 15;21(1):329.
  • Evaluation of the Coverage of 3 Antibiotic Regimens for Neonatal Sepsis in the Hospital Setting Across Asian Countries. Bielicki JA, Sharland M, Heath PT, Walker AS, Agarwal R, Turner P, Cromwell DA.JAMA Netw Open. 2020 Feb 5;3(2):e1921124.
  • Randomized clinical trial of DTaP5-HB-IPV-Hib vaccine administered concomitantly with meningococcal serogroup C conjugate vaccines during the primary infant series. Oliver JL, Sadorge C, Boisnard F, Snape MD, Tomlinson R, Mann R, Rudd P, Bhakthavalsala S, Faust SN, Heath PT, Hughes SM, Borrow R, Thomas S, Finn A. Vaccine. 2020 Jul 9:S0264-410X(20)30787-8
  • Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial. Folegatti PM, Ewer KJ, Aley PK, Angus B, Becker S, Belij-Rammerstorfer S, Bellamy D, Bibi S, Bittaye M, Clutterbuck EA, Dold C, Faust SN, Finn A, Flaxman AL, Hallis B, Heath P, Jenkin D, Lazarus R, Makinson R, Minassian AM, Pollock KM, Ramasamy M, Robinson H, Snape M, Tarrant R, Voysey M, Green C, Douglas AD, Hill AVS, Lambe T, Gilbert SC, Pollard AJ; Oxford COVID Vaccine Trial Group. Lancet. 2020 Jul 20:S0140-6736(20)31604-4.
  • Uncovering infant group B streptococcal (GBS) disease clusters in the UK and Ireland through genomic analysis: a population-based epidemiological study. Collin SM, Groves N, O'Sullivan C, Jauneikaite E, Patel D, Cunney R, Meehan M, Reynolds A, Smith A, Lindsay D, Doherty L, Davies E, Chalker V, Lamb P, Afshar B, Balasegaram S, Coelho J, Ready D, Brown CS, Efstratiou A, Le Doare K, Sriskandan S, Heath PT, Lamagni T. Clin Infect Dis. 2020 Aug 7:ciaa1087.
  • Respiratory Syncytial Virus Vaccination during Pregnancy and Effects in Infants. Madhi SA, Polack FP, Piedra PA, Munoz FM, Trenholme AA, Simões EAF, Swamy GK, Agrawal S, Ahmed K, August A, Baqui AH, Calvert A, Chen J, Cho I, Cotton MF, Cutland CL, Englund JA, Fix A, Gonik B, Hammitt L, Heath PT, de Jesus JN, Jones CE, Khalil A, Kimberlin DW, Libster R, Llapur CJ, Lucero M, Pérez Marc G, Marshall HS, Masenya MS, Martinón-Torres F, Meece JK, Nolan TM, Osman A, Perrett KP, Plested JS, Richmond PC, Snape MD, Shakib JH, Shinde V, Stoney T, Thomas DN, Tita AT, Varner MW, Vatish M, Vrbicky K, Wen J, Zaman K, Zar HJ, Glenn GM, Fries LF; Prepare Study Group.N Engl J Med. 2020 Jul 30;383(5):426-439
  • SARS-CoV-2 infection in pregnancy: A systematic review and meta-analysis of clinical features and pregnancy outcomes. Khalil A, Kalafat E, Benlioglu C, O'Brien P, Morris E, Draycott T, Thangaratinam S, Le Doare K, Heath P, Ladhani S, von Dadelszen P, Magee LA. EClinicalMedicine. 2020 Jul 3:10044
  • Infant Group B Streptococcal Disease Incidence and Antimicrobial Resistance in China: Systematic Review and Meta-analyses. Yijun Ding, Yajuan Wang,Yingfen Hsia, Neal Russell, Paul T. Heath. Emerging Infectious Diseases 2020 (in press)
  • Parenting a child with congenital cytomegalovirus infection: a qualitative study. Vandrevala T, Barber V, Mbire-Chigumba E, Calvert A, Star C, Khalil A, Griffiths P, Book AS, Book GM, Heath P, Jones CE.BMJ Paediatr Open. 2020 Nov 12;4(1):e000844
  • Group B Streptococcal disease in England (1998 - 2017): a population based observational study. Kadambari S, Trotter CL, Heath PT, Goldacre MJ, Pollard AJ, Goldacre R.Clin Infect Dis. 2020 Sep 29:ciaa1485.
  • C-Reactive Protein, Procalcitonin, and White Blood Count to Rule Out Neonatal Early-onset Sepsis Within 36 Hours: A Secondary Analysis of the Neonatal Procalcitonin Intervention Study. Stocker M, van Herk W, El Helou S, Dutta S, Schuerman FABA, van den Tooren-de Groot RK, Wieringa JW, Janota J, van der Meer-Kappelle LH, Moonen R, Sie SD, de Vries E, Donker AE, Zimmerman U, Schlapbach LJ, de Mol AC, Hoffman-Haringsma A, Roy M, Tomaske M, F Kornelisse R, van Gijsel J, Visser EG, Plötz FB, Heath P, Achten NB, Lehnick D, van Rossum AMC. Clin Infect Dis. 2020 Sep 3:ciaa876.
  • Detection of group B streptococcus colonisation in pregnant women: comparison of two different culture methods and study of antimicrobial resistance patterns. Carreras-Abad C, To KN, Ramkhelawon L, Planche T, Monahan I, Djennad A, Chalker V, Heath PT, Doare KL.J Infect. 2021 Jan 8
  • Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK.Voysey M, Clemens SAC, Madhi SA, Weckx LY, Folegatti PM, Aley PK, Angus B, Baillie VL, Barnabas SL, Bhorat QE, Bibi S, Briner C, Cicconi P, Collins AM, Colin-Jones R, Cutland CL, Darton TC, Dheda K, Duncan CJA, Emary KRW, Ewer KJ, Fairlie L, Faust SN, Feng S, Ferreira DM, Finn A, Goodman AL, Green CM, Green CA, Heath PT, Hill C, Hill H, Hirsch I, Hodgson SHC, Izu A, Jackson S, Jenkin D, Joe CCD, Kerridge S, Koen A, Kwatra G, Lazarus R, Lawrie AM, Lelliott A, Libri V, Lillie PJ, Mallory R, Mendes AVA, Milan EP, Minassian AM, McGregor A, Morrison H, Mujadidi YF, Nana A, O'Reilly PJ, Padayachee SD, Pittella A, Plested E, Pollock KM, Ramasamy MN, Rhead S, Schwarzbold AV, Singh N, Smith A, Song R, Snape MD, Sprinz E, Sutherland RK, Tarrant R, Thomson EC, Török ME, Toshner M, Turner DPJ, Vekemans J, Villafana TL, Watson MEE, Williams CJ, Douglas AD, Hill AVS, Lambe T, Gilbert SC, Pollard AJ; Oxford COVID Vaccine Trial Group.Lancet. 2021 Jan 9;397(10269):99-111.
  • Meningococcal carriage in periods of high and low invasive meningococcal disease incidence in the UK: comparison of UKMenCar1-4 cross-sectional survey results. MacLennan JM, Rodrigues CMC, Bratcher HB, Lekshmi A, Finn A, Oliver J, Wootton M, Ray S, Cameron C, Smith A, Heath PT, Bartolf A, Nolan T, Hughes S, Varghese A, Snape MD, Sewell R, Cunningham R, Stolton A, Kay C, Palmer K, Baxter D, Suggitt D, Zipitis CS, Pemberton N, Jolley KA, Bray JE, Harrison OB, Ladhani SN, Pollard AJ, Borrow R, Gray SJ, Trotter C, Maiden MCJ. Lancet Infect Dis. 2021 Jan 19:S1473-3099(20)30842-2
  • Persistence of SARS-CoV-2 N-Antibody Response in Healthcare Workers, London, UK. Shrotri M, Harris RJ, Rodger A, Planche T, Sanderson F, Mahungu T, McGregor A, Heath PT; LondonCOVID Group, Brown CS, Dunning J, Hopkins S, Ladhani S, Chand M. Emerg Infect Dis. 2021 Mar 18;27(4):1155-1158
  • Reliability of dried blood spot (DBS) cards in antibody measurement: A systematic review. Amini F, Auma E, Hsia Y, Bilton S, Hall T, Ramkhelawon L, Heath PT, Le Doare K.PLoS One. 2021 Mar 15;16(3):e0248218.
  • Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B.1.1.7): an exploratory analysis of a randomised controlled trial. Emary KRW, Golubchik T, Aley PK, Ariani CV, Angus B, Bibi S, Blane B, Bonsall D, Cicconi P, Charlton S, Clutterbuck EA, Collins AM, Cox T, Darton TC, Dold C, Douglas AD, Duncan CJA, Ewer KJ, Flaxman AL, Faust SN, Ferreira DM, Feng S, Finn A, Folegatti PM, Fuskova M, Galiza E, Goodman AL, Green CM, Green CA, Greenland M, Hallis B, Heath PT, Hay J, Hill HC, Jenkin D, Kerridge S, Lazarus R, Libri V, Lillie PJ, Ludden C, Marchevsky NG, Minassian AM, McGregor AC, Mujadidi YF, Phillips DJ, Plested E, Pollock KM, Robinson H, Smith A, Song R, Snape MD, Sutherland RK, Thomson EC, Toshner M, Turner DPJ, Vekemans J, Villafana TL, Williams CJ, Hill AVS, Lambe T, Gilbert SC, Voysey M, Ramasamy MN, Pollard AJ; COVID-19 Genomics UK consortium; AMPHEUS Project; Oxford COVID-19 Vaccine Trial Group. Lancet. 2021 Mar 30
  • Listeria infection in young infants: results from a national surveillance study in the UK and Ireland. Vergnano S, Godbole G, Simbo A, Smith-Palmer A, Cormican M, Mark A, Heath PT. Arch Dis Child. 2021 May 13
  • Post-licensure observational safety study after meningococcal B vaccine 4CMenB (Bexsero) vaccination within the routine UK immunisation program. Hall GC, Douglas I, Heath PT, Prabhakar P, Rosillon D, Khan J, Abbing-Karahagopian V. Vaccine. 2021 May 4:S0264-410X(21)00256-5
  • Safety and immunogenicity of heterologous versus homologous prime-boost schedules with an adenoviral vectored and mRNA COVID-19 vaccine (Com-COV): a single-blind, randomised, non-inferiority trial. Liu X, Shaw RH, Stuart ASV, Greenland M, Aley PK, Andrews NJ, Cameron JC, Charlton S, Clutterbuck EA, Collins AM, Dinesh T, England A, Faust SN, Ferreira DM, Finn A, Green CA, Hallis B, Heath PT, Hill H, Lambe T, Lazarus R, Libri V, Long F, Mujadidi YF, Plested EL, Provstgaard-Morys S, Ramasamy MN, Ramsay M, Read RC, Robinson H, Singh N, Turner DPJ, Turner PJ, Walker LL, White R, Nguyen-Van-Tam JS, Snape MD; Com-COV Study Group. Lancet. 2021 Sep 4;398(10303):856-869
  • Understanding pregnant women's readiness to engage in risk-reducing measures to prevent infections during pregnancy.Vandrevala T, Barber V, Calvert A, Star C, Khalil A, Griffiths P, Heath PT, Jones CE.J Health Psychol. 2021 Sep;26(10):1728-1740.
  • Changing knowledge, attitudes and behaviours towards cytomegalovirus in pregnancy through film-based antenatal education: a feasibility randomised controlled trial of a digital educational intervention. Calvert A, Vandrevala T, Parsons R, Barber V, Book A, Book G, Carrington D, Greening V, Griffiths P, Hake D, Khalil A, Luck S, Montague A, Star C, Ster IC, Wood S, Heath PT, Jones CE. BMC Pregnancy Childbirth. 2021 Aug 18;21(1):565.
  • COVID-19 Vaccination During Pregnancy: Coverage and Safety. Blakeway H, Prasad S, Kalafat E, Heath PT, Ladhani SN, Le Doare K, Magee LA, O'brien P, Rezvani A, Dadelszen PV, Khalil A. Am J Obstet Gynecol. 2021 Aug 10
  • Safety and Efficacy of NVX-CoV2373 Covid-19 Vaccine. Heath PT, Galiza EP, Baxter DN, Boffito M, Browne D, Burns F, Chadwick DR, Clark R, Cosgrove C, Galloway J, Goodman AL, Heer A, Higham A, Iyengar S, Jamal A, Jeanes C, Kalra PA, Kyriakidou C, McAuley DF, Meyrick A, Minassian AM, Minton J, Moore P, Munsoor I, Nicholls H, Osanlou O, Packham J, Pretswell CH, San Francisco Ramos A, Saralaya D, Sheridan RP, Smith R, Soiza RL, Swift PA, Thomson EC, Turner J, Viljoen ME, Albert G, Cho I, Dubovsky F, Glenn G, Rivers J, Robertson A, Smith K, Toback S; 2019nCoV-302 Study Group.N Engl J Med. 2021 Jun 30
  • Antibiotic Susceptibility, Virulome, and Clinical Outcomes in European Infants with Bloodstream Infections Caused by Enterobacterales. Folgori L, Di Carlo D, Comandatore F, Piazza A, Witney AA, Bresesti I, Hsia Y, Laing K, Monahan I, Bielicki J, Alvaro A, Zuccotti GV, Planche T, Heath PT, Sharland M. Antibiotics (Basel). 2021 Jun 11;10(6):706.
  • A phase IV, multi-centre, randomized clinical trial comparing two pertussis-containing vaccines in pregnant women in England and vaccine responses in their infants. Jones CE, Calvert A, Southern J, Matheson M, Andrews N, Khalil A, Cuthbertson H, Hallis B, England A, Heath PT, Miller E.BMC Med. 2021 Jun 8;19(1):138.
  • Invasive Group B Streptococcus Disease With Recurrence and in Multiples: Towards a Better Understanding of GBS Late-Onset Sepsis. Freudenhammer M, Karampatsas K, Le Doare K, Lander F, Armann J, Acero Moreno D, Boyle M, Buxmann H, Campbell R, Chalker V, Cunney R, Doherty L, Davies E, Efstratiou A, Elling R, Endmann M, Essers J, Hentschel R, Jones CE, Kallsen S, Kapatai G, Krüger M, Ladhani S, Lamagni T, Lindsay D, Meehan M, O'Sullivan CP, Patel D, Reynolds AJ, Roll C, Schulzke S, Smith A, Stein A, von der Wense A, Voss E, Wieg C, Härtel C, Heath PT, Henneke P.Front Immunol. 2021 Jun 2
  • Safety, immunogenicity, and efficacy of a COVID-19 vaccine (NVX-CoV2373) co-administered with seasonal influenza vaccines: an exploratory substudy of a randomised, observer-blinded, placebo-controlled, phase 3 trial. Toback S, Galiza E, Cosgrove C, Galloway J, Goodman AL, Swift PA, Rajaram S, Graves-Jones A, Edelman J, Burns F, Minassian AM, Cho I, Kumar L, Plested JS, Rivers EJ, Robertson A, Dubovsky F, Glenn G, Heath PT; 2019nCoV-302 Study Group. Lancet Respir Med. 2021 Nov 17:S2213-2600(21)00409-4.
  • COVID-19 vaccination in pregnancy-number needed to vaccinate to avoid harm. Magee LA, von Dadelszen P, Kalafat E, Duncan EL, O'Brien P, Morris E, Heath P, Khalil A. Lancet Infect Dis. 2021 Nov 2:S1473-3099(21)00691-5.
  • Incidental findings in UK healthy volunteers screened for a COVID-19 vaccine trial. Hodgson SH, Iveson P, Larwood J, Roche S, Morrison H, Cosgrove C, Galiza E, Ikram S, Lemm NM, Mehdipour S, Owens D, Pacurar M, Schumacher M, Shaw RH, Faust SN, Heath PT, Pollard AJ, Emary KRW, Pollock KM, Lazarus R. Clin Transl Sci. 2021 Oct 20.
  • SARS-CoV-2 Infection in an Adolescent With X-linked Agammaglobulinemia. Pereira NMD, Heath PT, Doerholt K, Almario-Hernandez AF, Gilmour C, Drysdale SB. Pediatr Infect Dis J. 2021 Sep 28;40(12):e472-4.
  • Applicability of the GAIA Maternal and Neonatal Outcome Case Definitions for the Evaluation of Adverse Events Following Vaccination in Pregnancy in High-income Countries. Watson G, Dodd C, Munoz FM, Eckert LO, Jones CE, Buttery JP, Yildirim IB, Kachikis A, Heath PT, Schlaudecker EP, Bond NH, Santarcangelo PL, Wilcox CR, Bellamy K, Elmontser M, Sienas L, Simon R, Khalil A, Townsend R, Sturkenboom M, Black S. Pediatr Infect Dis J. 2021 Sep 28.
  • Experiences of pregnant women and healthcare professionals of participating in a digital antenatal CMV education intervention.Montague A, Vandrevala T, Calvert A, Yeh IL, Star C, Khalil A, Griffiths P, Heath PT, Jones CE. Midwifery. 2022 Mar;106:103249
  • Immunogenicity, safety, and reactogenicity of heterologous COVID-19 primary vaccination incorporating mRNA, viral-vector, and protein-adjuvant vaccines in the UK (Com-COV2): a single-blind, randomised, phase 2, non-inferiority trial. Stuart ASV, Shaw RH, Liu X, Greenland M, Aley PK, Andrews NJ, Cameron JC, Charlton S, Clutterbuck EA, Collins AM, Darton T, Dinesh T, Duncan CJA, England A, Faust SN, Ferreira DM, Finn A, Goodman AL, Green CA, Hallis B, Heath PT, Hill H, Horsington BM, Lambe T, Lazarus R, Libri V, Lillie PJ, Mujadidi YF, Payne R, Plested EL, Provstgaard-Morys S, Ramasamy MN, Ramsay M, Read RC, Robinson H, Screaton GR, Singh N, Turner DPJ, Turner PJ, Vichos I, White R, Nguyen-Van-Tam JS, Snape MD; Com-COV2 Study Group. Lancet. 2022 Jan 1;399(10319):36-49. doi: 10.1016/S0140-6736(21)02718-5
  • Optimised versus standard dosing of vancomycin in infants with Gram-positive sepsis (NeoVanc): a multicentre, randomised, open-label, phase 2b, non-inferiority trial. Hill LF, Clements MN, Turner MA, Donà D, Lutsar I, Jacqz-Aigrain E, Heath PT, Roilides E, Rawcliffe L, Alonso-Diaz C, Baraldi E, Dotta A, Ilmoja ML, Mahaveer A, Metsvaht T, Mitsiakos G, Papaevangelou V, Sarafidis K, Walker AS, Sharland M; NeoVanc Consortium. Lancet Child Adolesc Health. 2022 Jan;6(1):49-59.
  • Synbiotics to prevent necrotising enterocolitis in very preterm or very low birth weight infants. Sharif S, Heath PT, Oddie SJ, McGuire W. Cochrane Database Syst Rev. 2022 Mar 1;3(3):CD014067
  • Comparison of neurodevelopmental outcomes in children with GBS Sepsis and Meningitis. Davies HG, O'Sullivan CP, Al Janabi H, Rattue H, Trotter C, Mary Ramsay KG, Ladhani S, Lamagni T, Okike IO, Le Doare K, Heath PT.Clin Infect Dis. 2022 Apr 20
  • Clinical Risk Factors Associated with Late-Onset Invasive Group B Streptococcal Disease: Systematic Review and Meta-analyses.Karampatsas K, Davies H, Mynarek M, Andrews N, Heath PT, Le Doare K.Clin Infect Dis. 2022 Mar 11
  • Vestibular and balance dysfunction in children with congenital CMV: a systematic review. Shears A, Yan G, Mortimer H, Cross E, Sapuan S, Kadambari S, Luck S, Heath PT, Walter S, Fidler KJ. Arch Dis Child Fetal Neonatal Ed. 2022 May 11
  • Systematic review and meta-analysis of the effectiveness and perinatal outcomes of COVID-19 vaccination in pregnancy. Prasad S, Kalafat E, Blakeway H, Townsend R, O'Brien P, Morris E, Draycott T, Thangaratinam S, Le Doare K, Ladhani S, von Dadelszen P, Magee LA, Heath P, Khalil A. Nat Commun. 2022 May 10;13(1):2414.
  • PEPtalk 3: oral aciclovir is equivalent to varicella zoster immunoglobulin as postexposure prophylaxis against chickenpox in children with cancer - results of a multicentre UK evaluation. Cuerden C, Gower C, Brown K, Heath PT, Andrews N, Amirthalingam G, Bate J. Arch Dis Child. 2022 Jul 8
  • Comparing Reactogenicity of COVID-19 vaccines: a systematic review and meta-analysis. Sutton N, San Francisco Ramos A, Beales E, Smith D, Ikram S, Galiza E, Hsia Y, Heath PT. Expert Rev Vaccines. 2022 Jul
  • Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine in children aged 6-17 years: a preliminary report of COV006, a phase 2 single-blind, randomised, controlled trial. Li G, Cappuccini F, Marchevsky NG, Aley PK, Aley R, Anslow R, Bibi S, Cathie K, Clutterbuck E, Faust SN, Feng S, Heath PT, Kerridge S, Lelliott A, Mujadidi Y, Ng KF, Rhead S, Roberts H, Robinson H, Roderick MR, Singh N, Smith D, Snape MD, Song R, Tang K, Yao A, Liu X, Lambe T, Pollard AJ; COV006 study team. Lancet. 2022 Jun 11;399(10342):2212-2225
  • Effect of priming interval on reactogenicity, peak immunological response, and waning after homologous and heterologous COVID-19 vaccine schedules: exploratory analyses of Com-COV, a randomised control trial. Shaw RH, Liu X, Stuart ASV, Greenland M, Aley PK, Andrews NJ, Cameron JC, Charlton S, Clutterbuck EA, Collins AM, Dejnirattisai W, Dinesh T, Faust SN, Ferreira DM, Finn A, Green CA, Hallis B, Heath PT, Hill H, Lambe T, Lazarus R, Libri V, Long F, Mujadidi YF, Plested EL, Morey ER, Provstgaard-Morys S, Ramasamy MN, Ramsay M, Read RC, Robinson H, Screaton GR, Singh N, Turner DPJ, Turner PJ, Vichos I, Walker LL, White R, Nguyen-Van-Tam JS, Snape MD; Com-COV Study Group. Lancet Respir Med. 2022 Jun 8:S2213-2600
  • An observational, cohort, multi-centre, open label phase IV extension study comparing preschool DTAP-IPV booster vaccine responses in children whose mothers were randomised to one of two pertussis-containing vaccines or received no pertussis-containing vaccine in pregnancy in England. Sapuan S, Andrews N, Hallis B, Hole L, Jones CE, Matheson M, Miller E, Snape MD, Heath PT. Vaccine. 2022 Oct 19
  • Safety and Efficacy of the NVX-CoV2373 COVID-19 Vaccine at Completion of the Placebo-Controlled Phase of a Randomized Controlled Trial. Heath PT, Galiza EP, Baxter DN, Boffito M, Browne D, Burns F, Chadwick DR, Clark R, Cosgrove CA, Galloway J, Goodman AL, Heer A, Higham A, Iyengar S, Jeanes C, Kalra PA, Kyriakidou C, Bradley JM, Munthali C, Minassian AM, McGill F, Moore P, Munsoor I, Nicholls H, Osanlou O, Packham J, Pretswell CH, Francisco Ramos AS, Saralaya D, Sheridan RP, Smith R, Soiza RL, Swift PA, Thomson EC, Turner J, Viljoen ME, Fries L, Cho I, McKnight I, Glenn G, Rivers EJ, Robertson A, Alves K, Smith K, Toback S. Clin Infect Dis. 2022 Oct 10
  • A systematic review and meta-analysis of the prevalence of human cytomegalovirus shedding in seropositive pregnant women.Sapuan S, Theodosiou AA, Strang BL, Heath PT, Jones CE.Rev Med Virol. 2022 Oct 5
  • Evaluation of immunogenicity and reactogenicity of COVID-19 vaccines in pregnant women. Blakeway H, Amin-Chowdhury Z, Prasad S, Kalafat E, Ismail M, Abdallah FN, Rezvani A, Amirthalingam G, Brown K, Le Doare K, Heath PT, Ladhani SN, Khalil A. Ultrasound Obstet Gynecol. 2022 Nov;60(5):673-680
  • Impact of meningococcal ACWY conjugate vaccines on pharyngeal carriage in adolescents: evidence for herd protection from the UK MenACWY programme. Carr JP, MacLennan JM, Plested E, Bratcher HB, Harrison OB, Aley PK, Bray JE, Camara S, Rodrigues CMC, Davis K, Bartolf A, Baxter D, Cameron JC, Cunningham R, Faust SN, Fidler K, Gowda R, Heath PT, Hughes S, Khajuria S, Orr D, Raman M, Smith A, Turner DPJ, Whittaker E, Williams CJ, Zipitis CS, Pollard AJ, Oliver J, Morales-Aza B, Lekshmi A, Clark SA, Borrow R, Christensen H, Trotter C, Finn A, Maiden MC, Snape MD; UKMenCar4 and ‘Be on the TEAM’ Study Collaborators.Clin Microbiol Infect. 2022 Dec;28(12):1649.e1-1649.e8.
  • Managing challenges in congenital CMV: current thinking. Jones CE, Bailey H, Bamford A, Calvert A, Dorey RB, Drysdale SB, Khalil A, Heath PT, Lyall H, Ralph KMI, Sapuan S, Vandrevala T, Walter S, Whittaker E, Wood S; UK Congenital CMV Infection Collaboration (UKCCIC). Arch Dis Child. 2022 Nov 28
  • Incidence of Group B Streptococcus Disease in Infants in China: An Updated Systematic Review and Meta-analysis. Ding Y, Hsia Y, O'Sullivan C, Wang Y, Heath PT. Pediatr Infect Dis J. 2023 Jan 1;42(1):e15-e17
  • Neonatal invasive candidiasis in low-and-middle-income countries: data from the NeoOBS study. Cook A, Ferreras-Antolin L, Adhisivam B, Ballot D, Berkley JA, Bernaschi P, Carvalheiro CG, Chaikittisuk N, Chen Y, Chibabhai V, Chitkara S, Chiurchiu S, Chorafa E, Dien TM, Dramowski A, de Matos SF, Feng J, Jarovsky D, Kaur R, Khamjakkaew W, Laoyookhong P, Machanja E, Mussi-Pinhata MM, Namiiro F, Natraj G, Naziat H, Ngoc HTB, Ondongo-Ezhet C, Preedisripipat K, Rahman H, Riddell A, Roilides E, Russell N, Sastry AS, Tasimwa HB, Tongzhen J, Wadula J, Wang Y, Whitelaw A, Wu D, Yadav V, Yang G, Stohr W, Bielicki JA, Ellis S, Warris A,Heath PT, Sharland. M.Med Mycol. 2023 Mar 6
  • Effect of maternal immunisation with multivalent vaccines containing inactivated poliovirus vaccine (IPV) on infant IPV immune response: A phase 4, multi-centre randomised trial. Grassly NC, Andrews N, Cooper G, Stephens L, Waight P, Jones CE, Heath PT, Calvert A, Southern J, Martin J, Miller E.Vaccine. 2023 Feb 10;41(7):1299-1302
  • Using Dried Blood Spots for a Sero-Surveillance Study of Maternally Derived Antibody against Group B Streptococcus. Auma E, Hall T, Chopra S, Bilton S, Ramkhelawon L, Amini F, Calvert A, Amirthalingam G, Jones CE, Andrews N, Heath PT, Le Doare K.Vaccines (Basel). 2023 Feb 4;11(2):357.
  • Calvert A, Karampatsas K, Andrews N, et al. Optimising the timing of whooping cough Immunisation in MUMs: a randomised controlled trial investigating the timing of pertussis vaccination in pregnancy (OpTIMUM): a protocol paper. Wellcome Open Res 2021; 6: 1.
  • Optimising the timing of whooping cough immunisation in mums (OpTIMUM) through investigating pertussis vaccination in pregnancy: an open-label, non-inferiority, randomised controlled trial. Anna Calvert, Gayatri Amirthalingam, Nick Andrews, Sneha Basude, Matthew Coleman, Hannah Cuthbertson, Anna England, Vanessa Greening, Bassam Hallis, Edward Johnstone, Christine E Jones, Konstantinos Karampatsas, Asma Khalil, Kirsty Le Doare, Mary Matheson, Elisabeth Peregrine, Matthew D Snape, Manu Vatish, Paul T Heath, on behalf of the OpTIMUM Study Group* Lancet Microbe 2023 (in press)
  • Omicron BA.1-containing mRNA-1273 boosters compared with the original COVID-19 vaccine in the UK: a randomised, observer-blind, active-controlled trial. Lee IT, Cosgrove CA, Moore P, Bethune C, Nally R, Bula M, Kalra PA, Clark R, Dargan PI, Boffito M, Sheridan R, Moran E, Darton TC, Burns F, Saralaya D, Duncan CJA, Lillie PJ, San Francisco Ramos A, Galiza EP, Heath PT, Girard B, Parker C, Rust D, Mehta S, de Windt E, Sutherland A, Tomassini JE, Dutko FJ, Chalkias S, Deng W, Chen X, Feng J, Tracy L, Zhou H, Miller JM, Das R; Study Investigators. Lancet Infect Dis. 2023 Sep;23(9):1007-1019.
  • Reactogenicity, immunogenicity and breakthrough infections following heterologous or fractional second dose COVID-19 vaccination in adolescents (Com-COV3): A randomised controlled trial. Kelly E, Greenland M, de Whalley PCS, Aley PK, Plested EL, Singh N, Koleva S, Tonner S, Macaulay GC, Read RC, Ramsay M, Cameron JC, Turner DPJ, Heath PT, Bernatoniene J, Connor P, Cathie K, Faust SN, Banerjee I, Cantrell L, Mujadidi YF, Belhadef HT, Clutterbuck EA, Anslow R, Valliji Z, James T, Hallis B, Otter AD, Lambe T, Nguyen-Van-Tam JS, Minassian AM, Liu X, Snape MD; Com-COV3 Study Group. J Infect. 2023 Sep;87(3):230-241
  • Comparison of diagnoses of early-onset sepsis associated with use of Sepsis Risk Calculator versus NICE CG149: a prospective, population-wide cohort study in London, UK, 2020-2021. Piyasena C, Galu S, Yoshida R, Thakkar D, O'Sullivan J, Longley C, Evans K, Sweeney S, Kendall G, Ben-Sasi K, Richards J, Harris C, Jagodzinski J, Demirjian A, Lamagni T, Le Doare K, Heath PT, Battersby C; Neonatal Trainee-Led Research and Improvement Projects (NeoTRIPs) group. BMJ Open. 2023 Jul 27;13(7):e072708.
  • Standardizing case definitions for monitoring the safety of maternal vaccines globally: GAIA definitions, a review of progress to date. Davies HG, Bowman C, Watson G, Dodd C, Jones CE, Munoz FM, Heath PT, Cutland CL, Le Doare K. Int J Gynaecol Obstet. 2023 Jul;162(1):29-38.
  • Patterns of antibiotic use, pathogens, and prediction of mortality in hospitalized neonates and young infants with sepsis: A global neonatal sepsis observational cohort study (NeoOBS). Russell NJ, Stöhr W, Plakkal N, Cook A, Berkley JA, Adhisivam B, Agarwal R, Ahmed NU, Balasegaram M, Ballot D, Bekker A, Berezin EN, Bilardi D, Boonkasidecha S, Carvalheiro CG, Chami N, Chaurasia S, Chiurchiu S, Colas VRF, Cousens S, Cressey TR, de Assis ACD, Dien TM, Ding Y, Dung NT, Dong H, Dramowski A, Ds M, Dudeja A, Feng J, Glupczynski Y, Goel S, Goossens H, Hao DTH, Khan MI, Huertas TM, Islam MS, Jarovsky D, Khavessian N, Khorana M, Kontou A, Kostyanev T, Laoyookhon P, Lochindarat S, Larsson M, Luca M, Malhotra-Kumar S, Mondal N, Mundhra N, Musoke P, Mussi-Pinhata MM, Nanavati R, Nakwa F, Nangia S, Nankunda J, Nardone A, Nyaoke B, Obiero CW, Owor M, Ping W, Preedisripipat K, Qazi S, Qi L, Ramdin T, Riddell A, Romani L, Roysuwan P, Saggers R, Roilides E, Saha SK, Sarafidis K, Tusubira V, Thomas R, Velaphi S, Vilken T, Wang X, Wang Y, Yang Y, Zunjie L, Ellis S, Bielicki JA, Walker AS, Heath PT, Sharland M. PLoS Med. 2023 Jun 8;20(6):e1004179.
  • Persistence of immune response in heterologous COVID vaccination schedules in the Com-COV2 study - A single-blind, randomised trial incorporating mRNA, viral-vector and protein-adjuvant vaccines. Shaw RH, Greenland M, Stuart ASV, Aley PK, Andrews NJ, Cameron JC, Charlton S, Clutterbuck EA, Collins AM, Darton T, Dinesh T, Duncan CJA, Faust SN, Ferreira DM, Finn A, Goodman AL, Green CA, Hallis B, Heath PT, Hill H, Lambe T, Libri V, Lillie PJ, Morey E, Mujadidi YF, Payne R, Plested EL, Provstgaard-Morys S, Ramasamy MN, Ramsay M, Read RC, Robinson H, Screaton GR, Singh N, Turner DPJ, Turner PJ, White R, Nguyen-Van-Tam JS, Liu X, Snape MD; Com-COV2 Study Group. J Infect. 2023 Jun;86(6):574-583.
  • Challenges in the Implementation of the NeoOBS Study, a Global Pragmatic Observational Cohort Study, to Investigate the Aetiology and Management of Neonatal Sepsis in the Hospital Setting. Riddell A, Cook A, Khavessian N, Ellis S, Bilardi D, Correia E, Kostyanev T, Nardone A, Russell N, Vilken T, Stohr W, Adhisivam B, Moraes IRA, Ahmed NU, Bekker A, Berezin EN, Boonkasidecha S, Carvalheiro CG, Chauhan P, Chiurchiù S, Chorafa E, Dramowski A, Ds M, Feng J, Jia S, Kong Y, Kyohere M, Kontou A, Lochindarat S, De Luca M, Mphaphuli A, Mussi-Pinhata MM, Murunga S, Nakwa FL, Nangia S, Nassolo E, Hoang NTB, Obiero CW, Olson L, Ping W, Plakkal N, Prasad P, Preedisripipat K, Rahman SW, Seef T, Sukrakanchana PO, Thomas R, Yu Z, Zhang Q, Walker AS, Bielicki J, Heath PT, Sharland M, Munera-Huertas T. Antibiotics (Basel). 2023 May 17;12(5):923
  • Neonatal Group B Streptococcal Infection in Australia: A Case-control Study. Yanni M, Stark M, Francis L, Francis JR, McMillan M, Baird R, Heath PT, Gordon A, Riccardione J, Wilson A, Lee R, Chooi K, Quinn OP, Marshall HS. Pediatr Infect Dis J. 2023 May 1;42(5):429-435.
  • The propositive study: Immunogenicity and safety of a four-component recombinant protein-based vaccine against MenB and a quadrivalent conjugate MenACWY vaccine in people living with HIV. Isitt C, Bartolf A, Andrews N, Athaide S, Pryce-Williams R, Townsend-Payne K, Borrow R, Ladhani S, Heath PT, Cosgrove CA. HIV Med. 2023 Apr 23.
  • 2% chlorhexidine gluconate aqueous versus 2% chlorhexidine gluconate in 70% isopropyl alcohol for skin disinfection prior to percutaneous central venous catheterisation: the ARCTIC randomised controlled feasibility trial. Clarke P, Soe A, Nichols A, Harizaj H, Webber MA, Linsell L, Bell JL, Tremlett C, Muthukumar P, Pattnayak S, Partlett C, King A, Juszczak E,Heath PT. Arch Dis Child Fetal Neonatal Ed. 2023
  • Prebiotics to prevent necrotising enterocolitis in very preterm or very low birth weight infants. Sharif S, Oddie SJ, Heath PT, McGuire W. Cochrane Database Syst Rev. 2023 Jun 1;6(6)
  • Learning from the experiences of pregnant women participating in a research study investigating human cytomegalovirus shedding: A qualitative study. Sapuan S, Heath PT, Strang BL, Khalil A, Jones CE. PLoS One. 2023 Nov 30;18(11):e0292134
  • Propositive follow-up: Long-term immune responses to the 4CMenB and MenACWY vaccines in people living with HIV. San Francisco Ramos A, Isitt C, Athaide S, Ladhani SN, Andrews NJ, Townsend-Payne K, Holland A, Louth J, Borrow R, Heath PT, Cosgrove CA.HIV Med. 2023 Nov 28
  • THE PREDICTIVE ROLE OF SYMPTOMS IN COVID-19 DIAGNOSTIC MODELS – A LONGITUDINAL INSIGHT Olivia Bird,Eva P. Galiza, David Neil Baxter, Marta Boffito, Duncan Browne, Fiona Burns, David R. Chadwick, Rebecca Clark, Catherine A. Cosgrove, James Galloway, Anna L. Goodman, Amardeep Heer, Andrew Higham, Shalini Iyengar, Christopher Jeanes,,Philip A. Kalra, Christina Kyriakidou, Judy M. Bradley,17 Chigomezgo Munthali, Angela M. Minassian, Fiona McGill, Patrick Moore,Imrozia Munsoor, Helen Nicholls, Orod Osanlou, Jonathan Packham, Carol H. Pretswell, Alberto San Francisco Ramos, Dinesh Saralaya, Ray P. Sheridan, Richard Smith, Roy L. Soiza, Pauline A. Swift, Emma C. Thomson, Jeremy Turner, Marianne Elizabeth Viljoen, Paul T. Heath, and Irina Chis Ster. Epidemiology and Infection 2024 (in press)
  • Herbert MA, Heath PT, Mayon-White RT. Meningococcal vaccines for the United Kingdom.Communicable Disease Report 1995;5:R130-135
  • Heath PT, Moxon ER. Haemophilus influenzae type b vaccination. Journal of Family Medicine 1996;21:39-43.
  • Mayon-White RT, Heath PT. Annotation: "Preventative strategies on meningococcal disease". Archives of Disease in Childhood 1997;76 (3):178-81
  • Heath PT. " Haemophilus influenzae type b conjugate vaccines: a review of efficacy data". Paediatric Infectious Diseases Journal 1998;17:S36-42 .
  • Heath PT, Maclennan JM, Moxon ER. Polio vaccine: is it time for a change? Commentary. Archives of Disease in Childhood 1998;78:573-4
  • Heath PT, Moxon ER. "Haemophilus influenzae". Forfar & Arneil`s Textbook of Paediatrics. Fifth and Sixth Editions. Churchill Livingstone. (1998 and 2002).
  • Wenger J, Booy R, Heath PT, Moxon ER. "Epidemiologic impact of conjugate vaccines on invasive disease caused by Haemophilus influenzae type b." Levine et al (Ed). New Generation Vaccines. 2nd edition. Marcel Dekker, Inc. (1998).
  • Heath PT, Moxon ER. "Specific Vaccines." Root RK (Ed). Clinical Infectious Diseases: A Practical Approach. Oxford University Press. (1999).
  • Nicoll A, Heath PT. Group B Streptococcal infection. Commentary. Arch Dis Child Fetal Neonatal Ed 2000, 82(3) F207
  • Sidwell R, Heath PT. “Infectious Diseases”. Sidwell R, Thomson M (Eds). Concise Paediatrics.Greenwich Medical Media Ltd. (2000).
  • Heath PT. Epidemiology and bacteriology of bacterial pneumonias. Paediatric Respiratory Reviews 2000;1:4-7
  • Heath PT, Denvir L. Pertussis. MEDICINE 2001;29:3:91-92.
  • Heath PT. Bacterial infection and the neonate. Chapter in: Infection and Pregnancy, RCOG, 2000.
  • Heath PT, Breathnach AS.. Treatment of infections due to resistant organisms. In: Childhood Respiratory Infections. British Medical Bulletin 2002; 58(1): Chapter 15.
  • Mohan PV, Heath PT. Pneumococcal Disease in Childhood. Hospital Medicine 2001;62:406-9.
  • Coote NMA, Craig J, Heath PT, McKenzie SA, Saul P, Smyth R, Thomson AH. BTS Guidelines for the management of community acquired pneumonia in childhood. Thorax 2002;57: i1e24.
  • Heath PT, McVernon J. The UK Hib vaccine experience. Arch Dis Child 2002;86:396-99.
  • Finn A, Booy R, Moxon R, Sharland M, Heath P. Should the new pneumococcal vaccine be used in high-risk children? Arch Dis Child 2002;87:18-21.
  • Heath PT, Nik Yusoff NK, Baker CJ. Neonatal Meningitis. Arch Dis Child Fetal Neonatal Ed. 2003 88(3):F173-8.
  • Rueggeberg J, Heath PT. Safety and Efficacy of Meningococcal group C conjugate vaccines. Expert Opinion on Drug Safety. 2003;2(1): 7-79.
  • McVernon J, Heath PT. Re-inforcement of Hib immunisation required. Communicable Disease and Public Health. 2003;6(1):2.
  • Heath PT, Ramsay ME. Haemophilus influenzae type b vaccine--booster campaign. BMJ. 2003;326(7400):1158-9.
  • Vergnano S, Heath PT. Neisseria meningitidis serogroup A vaccines: an overview. Expert Rev. Vaccines 2003; 2(4):571-582.
  • Menson E, Heath PT. Strategies for preventing group B streptococcal disease. Adv Exp Med Biol, 549, 231-236 (2004).
  • Stefania Vergnano, Peter Kazembe, Charles Mwansambo, Mike Sharland, Paul T Heath. Neonatal sepsis: an international perspective. Arch Dis Child Fetal Neonatal Ed. 2005; 90(3):F220-4.
  • Law MR, Palomaki G, Alfirevic Z, Gilbert G, Heath P, McCartney C, Reid T, Schrag S. The prevention of neonatal Group B streptococcal disease. J Med Screen. 2005;12(2):60-8.
  • Heath PT, Feldman RG. Vaccination against Group B streptococcus. Expert Rev Vaccines. 2005;4(2):207-18.
  • Finn A, Heath P. Conjugate vaccines. Archives of Disease in Childhood 2005: 90: 667-9.
  • Sinha R, Heath PT. Pertussis. MEDICINE 2005;33: 101-2
  • Bonhoeffer, J, Heath PT. Update on new vaccines and immunisation strategies. Current Paediatrics. 2006;16:1-7.
  • Bonhoeffer, J, Siegrist, CA, Heath PT. Immunisation of premature infants. Archives of Disease in Childhood. 2006; 91:929-35
  • Heath PT. "Haemophilus influenzae". 7th Edition of Forfar and Arneil's Textbook of Pediatrics. Editors McIntosh, Helms, Smyth and Logan. 2007
  • Heath PT. “Infection and immunity in the newborn”. 7th Edition of Forfar and Arneil's Textbook of Pediatrics. Editors McIntosh, Helms, Smyth and Logan. 2007
  • Heath P and Schuchat A. “Perinatal Group B Streptococcal disease”. Best Pract Res Clin Obstet Gynaecol. 2007 Jun;21(3):411-24.
  • Erlewyn-Lajeunesse M, Bonhoeffer J, Ruggeberg JU, Heath PT. Anaphylaxis as an adverse event following immunization. J Clin Pathol. 2007 Jul;60(7):737-9.
  • Pneumococcal conjugate vaccines. A review. Minerva Med. 2007 Apr;98(2):131-43.
  • Conterno LO, Heath PT. Seroprotection against serogroup C meningococcal disease. BMJ. 2008 Jun 5
  • Patel SR, Chisholm JC, Heath PT. Vaccinations in children treated with standard-dose cancer therapy or hematopoietic stem cell transplantation. Pediatr Clin North Am. 2008 Feb;55(1):169-86
  • Soonie R Patel, Paul T Heath, Immunization in children with cancer. Paediatrics and Child Health 2008
  • Shamez Ladhani, Fiona Neely, Paul Heath, Bernadette Nazareth, Richard Roberts, Mary P.E. Slack, Jodie McVernon, Mary E. Ramsay Recommendations for the prevention of secondary Haemophilus influenzae type b (Hib) disease. Journal of Infection 2009.
  • Galiza EP, Heath PT. Improving the outcome of neonatal meningitis. Curr Opin Infect Dis 2009;22(3):229-34.
  • Galiza EP, Heath PT. Pertussis. Medicine. Volume 37, Issue 12, December 2009, Pages 635-637
  • Heath PT, Jardine LA. Neonatal infections: group B streptococcus. Clin Evid (Online). 2010 Sep 27;2010. pii: 0323.
  • Paul T. Heath, Ifeanyichukwu O. Okike Neonatal bacterial meningitis: an update. Paediatrics and Child Health, Volume 20, Issue 11, November 2010, Pages 526-530.
  • Bedford Russell A, Sharland M, Heath PT. Improving antibiotic prescribing in neonatal units: time to act. Arch. Dis. Child. Fetal Neonatal Ed. 2012;97 F141-F146
  • Heath PT, Okike IO, Oeser C. Neonatal meningitis: can we do better? Adv Exp Med Biol. 2011;719:11-24
  • Paul T. Heath, Chaamala L. Klinger and Christini Kortsalioudaki. Chapter: Group B Streptococcal Infections. In: “New Challenges in Prenatal and Neonatal Infections” 2011
  • Heath PT. An update on vaccination against group B streptococcus. Expert Rev Vaccines. 2011 May;10(5):685-94.
  • Borrow R, Heath PT, Siegrist CA. Use of pneumococcal polysaccharide vaccine in children: what is the evidence? Curr Opin Infect Dis. 2012 Apr 18
  • Guidance on vaccination of HIV-infected children in Europe. Menson E, Mellado M, Bamford A, Castelli G, Duiculescu D, MarczyƄska M, Navarro M, Scherpbier H, Heath P; the Paediatric European Network for Treatment of AIDS (PENTA) Vaccines Group, PENTA Steering Committee and Children's HIV Association (CHIVA). HIV Med. 2012 Jul;13(6):333-336.
  • Sharland M, Ladhani S, Ramsay M, Heath P, Saxena S, Koshy E, Bottle A, Murray J, Griffiths P. Chapter 6. Life Stage: Perinatal. Annual Report of the Chief Medical Officer. November 2012.
  • Okike IO, Lamont RF, Heath PT. Do we really need to worry about listeria in newborn infants? Pediatr Infect Dis J. 2013 Apr;32(4):405-6.
  • Managing and preventing outbreaks of Gram-negative infections in UK neonatal units. Anthony M, Bedford-Russell A, Cooper T, Fry C, Heath PT, Kennea N, McCartney M, Patel B, Pollard T, Sharland M, Wilson P. Arch Dis Child Fetal Neonatal Ed. 2013 Jun 21.
  • Cunnington M, Kortsalioudaki C, Heath P. Genitourinary pathogens and preterm birth. Curr Opin Infect Dis. 2013 Jun;26(3):219-30
  • Clinical trials in neonatal sepsis. Oeser C, Lutsar I, Metsvaht T, Turner MA, Heath PT, Sharland M. J Antimicrob Chemother. 2013 Jul 30
  • An overview of global GBS epidemiology. Le Doare K, Heath PT. Vaccine. 2013 Aug 28;31 Suppl 4:D7-D12.
  • Considerations for a phase-III trial to evaluate a group B Streptococcus polysaccharide-protein conjugate vaccine in pregnant women for the prevention of early- and late-onset invasive disease in young-infants. Madhi SA, Dangor Z, Heath PT, Schrag S, Izu A, Sobanjo-Ter Meulen A, Dull PM. Vaccine. 2013 Aug 28;31 Suppl 4:D52-7
  • Paul T. Heath and Luke Anthony Jardine. Neonatal infections: group B streptococcus. BMJ Clinical Evidence 2014.
  • Alison Kent, Mark A Turner, Mike Sharland and Paul T Heath. Aminoglycoside toxicity in neonates: something to worry about? Expert Rev. Anti Infect. Ther. 12(3), 319–331 (2014)
  • Empirical antibiotic cover for Listeria monocytogenes infection beyond the neonatal period: a time for change? Okike IO, Awofisayo A, Adak B, Heath PT. Arch Dis Child. 2015 May;100(5):423-5.
  • Antenatal immunization. Jones C, Heath P. Hum Vaccin Immunother. 2014;10(7):2118-22.
  • Vancomycin toxicity in neonates: a review of the evidence. Lestner JM, Hill LF, Heath PT, Sharland M. Curr Opin Infect Dis. 2016 Feb 18
  • Status of vaccine research and development of vaccines for GBS. Heath PT. Vaccine. 2016 Mar 15
  • Fifteen-minute consultation: diagnosis and management of congenital CMV. Shah T, Luck S, Sharland M, Kadambari S, Heath P, Lyall H. Arch Dis Child Educ Pract Ed. 2016 Oct;101(5):232-5
  • Appropriate surveillance methodology for assessing childhood antibiotic resistance: where do we stand? Bielicki JA, Heath PT, Sharland M. Future Microbiol. 2016 Sep;11:1109-12
  • Pre-Emptive Screening Strategies to Identify Postnatal CMV Diseases on the Neonatal Unit. Kadambari S, Luck S, Heath PT, Sharland M. Pediatr Infect Dis J. 2016 Oct;35(10):1148-50.
  • Maternal immunisation: collaborating with mother nature. Marchant A, Sadarangani M, Garand M, Dauby N, Verhasselt V, Pereira L, Bjornson G, Jones CE, Halperin SA, Edwards KM, Heath P, Openshaw PJ, Scheifele DW, Kollmann TR. Lancet Infect Dis. 2017 Jul;17(7):e197-e208
  • Antimicrobial-resistant Gram-negative infections in neonates: burden of disease and challenges in treatment. Folgori L, Bielicki J, Heath PT, Sharland M. Curr Opin Infect Dis. 2017 Jun;30(3):281-288
  • The Potential Role of Fosfomycin in Neonatal Sepsis Caused by Multidrug-Resistant Bacteria. Li G, Standing JF, Bielicki J, Hope W, van den Anker J, Heath PT, Sharland M. Drugs. 2017 Jun;77(9):941-950
  • Serious bacterial infections in neonates: improving reporting and case definitions. Vergnano S, Seale AC, Fitchett EJA, Sharland M, Heath PT. Int Health. 2017 May 1;9(3):148-155.
  • Group B Streptococcal Disease Worldwide for Pregnant Women, Stillbirths, and Children: Why, What, and How to Undertake Estimates? Lawn JE, Bianchi-Jassir F, Russell NJ, Kohli-Lynch M, Tann CJ, Hall J, Madrid L, Baker CJ, Bartlett L, Cutland C, Gravett MG, Heath PT, Ip M, Le Doare K, Madhi SA, Rubens CE, Saha SK, Schrag S, Sobanjo-Ter Meulen A, Vekemans J, Seale AC. Clin Infect Dis. 2017 Nov 6;65(suppl_2):S89-S99.
  • Tackling antimicrobial resistance in neonatal sepsis. Folgori L, Ellis SJ, Bielicki JA, Heath PT, Sharland M, Balasegaram M. Lancet Glob Health. 2017 Nov;5(11):e1066-e1068.
  • Maternal immunization against Group B streptococcus: World Health Organization research and development technological roadmap and preferred product characteristics. Vekemans J, Moorthy V, Friede M, Alderson MR, Sobanjo-Ter Meulen A, Baker CJ, Heath PT, Madhi SA, Mehring-Le Doare K, Saha SK, Schrag S, Kaslow DC. Vaccine. 2018 Feb 2. pii: S0264-410X(17)31359-2
  • The Fourth International Neonatal and Maternal Immunization Symposium (INMIS 2017): Toward Integrating Maternal and Infant Immunization Programs. Munoz FM, Van Damme P, Dinleyici E, Clarke E, Kampmann B, Heath PT, Levy O, Leuridan E, Cutland C, Sobanjo-Ter Meulen A, Marchant A. mSphere. 2018 Nov 7;3(6).
  • The use of polymyxins to treat carbapenem resistant infections in neonates and children. Thomas R, Velaphi S, Ellis S, Walker AS, Standing JF, Heath P, Sharland M, Dona' D. Expert Opin Pharmacother. 2018 Dec 21:1-8.
  • Serocorrelates of protection against infant group B streptococcus disease. Le Doare K, Kampmann B, Vekemans J, Heath PT, Goldblatt D, Nahm MH, Baker C, Edwards MS, Kwatra G, Andrews N, Madhi SA, Ter Meulen AS, Anderson AS, Corsaro B, Fischer P, Gorringe A. Lancet Infect Dis. 2019 May;19(5):e162-e171
  • Uncertainties in screening and prevention of Group B Streptococcus disease. Le Doare K, Heath PT, Plumb J, Owen NA, Brocklehurst P, Chappell LC. Clin Infect Dis. 2018 Dec 17. doi: 10.1093/cid/ciy1069.
  • The role of immune correlates of protection on the pathway to licensure, policy decision and use of group B Streptococcus vaccines for maternal immunization: considerations from World Health Organization consultations. Vekemans J, Crofts J, Baker CJ, Goldblatt D, Heath PT, Madhi SA, Le Doare K, Andrews N, Pollard AJ, Saha SK, Schrag SJ, Smith PG, Kaslow DC. Vaccine. 2019 May 27;37(24):3190-3198
  • Group B Streptococcus: Trials and Tribulations. Davies HG, Carreras-Abad C, Le Doare K, Heath PT. Pediatr Infect Dis J. 2019 Jun;38(6S Suppl 1):S72-S76
  • Strategic Trials to Define the Best Available Treatment for Neonatal and Pediatric Sepsis Caused by Carbapenem-resistant Organisms. Donà D, Sharland M, Heath PT, Folgori L. Pediatr Infect Dis J. 2019 Aug;38(8):825-827
  • A Vaccine Against Group B Streptococcus: Recent Advances. Carreras-Abad C, Ramkhelawon L, Heath PT, Le Doare K.Infect Drug Resist. 2020 Apr 29;13:1263-1272.
  • Inclusion of pregnant women in COVID-19 vaccine development. Heath PT, Le Doare K, Khalil A.Lancet Infect Dis. 2020 Sep;20(9):1007-1008.
  • The current state of immunization against Gram-negative bacteria in children: a review of the literature. Broad J, Le Doare K, Heath PT, Hallchurch P, Whelan I, Boyd H, Carruthers E, Sharland M, Ladhani S.Curr Opin Infect Dis. 2020 Dec;33(6):517-529
  • The Italian arm of the PREPARE study: an international project to evaluate and license a maternal vaccine against group B streptococcus. Berardi A, Cassetti T, Creti R, Vocale C, Ambretti S, Sarti M, Facchinetti F, Cose S; Prepare Network, Heath P, Le Doare K.Ital J Pediatr. 2020 Oct 28;46(1):160
  • The Fifth International Neonatal and Maternal Immunization Symposium (INMIS 2019): Securing Protection for the Next Generation. Sadarangani M, Kollmann T, Bjornson G, Heath P, Clarke E, Marchant A, Levy O, Leuridan E, Ulloa-Gutierrez R, Cutland CL, Kampmann B, Chaithongwongwatthana S, Dinleyici E, van Damme P, Munoz FM.mSphere. 2021 Jan 27;6(1):e00862-20.
  • Benefits and potential harms of COVID-19 vaccination during pregnancy: evidence summary for patient counseling. Kalafat E, O'Brien P, Heath PT, Le Doare K, von Dadelszen P, Magee L, Ladhani S, Khalil A. Ultrasound Obstet Gynecol. 2021 Mar 18.
  • Commentary: Perinatal Coronavirus Disease 2019 and Maternal Vaccination: What More Do We Need to Know? Heath PT, Munoz FM. Pediatr Infect Dis J. 2021 May 1;40(5):e193.
  • European Textbook on Pediatric Vaccines and Vaccination, 2nd Edition. New Vaccines in Pipeline Development (GBS/CMV). Christine E. Jones, Paul T. Heath, Kirsty Le Doare
  • European Textbook on Pediatric Vaccines and Vaccination, 2nd Edition. RSV Vaccines & immunoglobulins. Simon Drysdale, Eva Galiza, Paul T. Heath
  • European Textbook on Pediatric Vaccines and Vaccination, 2nd Edition. COVID-19 vaccines. Elizabeth Whittaker, Paul T. Heath
  • Prevention strategies for congenital cytomegalovirus infection. Tol I, Heath PT, Khalil A. Curr Opin Infect Dis. 2021 Oct 1;34(5):546-551
  • Maternal vaccination: A review of current evidence and recommendations. Etti M, Calvert A, Galiza E, Lim S, Khalil A, Le Doare K, Heath PT.Am J Obstet Gynecol. 2021 Nov 11:S0002-9378(21)01228-X.
  • COVID-19 booster doses in pregnancy and global vaccine equity. Kalafat E, Magee LA, von Dadelszen P, Heath P, Khalil A. Lancet. 2022 Mar 5;399(10328):907-908
  • COVID-19 vaccination in pregnancy. Kalafat E, Heath P, Prasad S, O Brien P, Khalil A. Am J Obstet Gynecol. 2022 May 11:S0002-9378(22)00364-7
  • Methodology for a correlate of protection for group B Streptococcus: Report from the Bill & Melinda Gates Foundation workshop held on 10 and 11 February 2021. Gilbert PB, Isbrucker R, Andrews N, Goldblatt D, Heath PT, Izu A, Madhi SA, Moulton L, Schrag SJ, Shang N, Siber G, Sobanjo-Ter Meulen A. Vaccine. 2022 Jun 29
  • Can the history of empiric antibiotic treatment for neonatal sepsis inform future global trials? Qazi S, Heath P, Balasegaram M, Bielicki J, Sharland M, Sharland E. Clin Microbiol Infect. 2022 Jun
  • Joint consensus statement on the vaccination of adult and paediatric haematopoietic stem cell transplant recipients: Prepared on behalf of the British society of blood and marrow transplantation and cellular therapy (BSBMTCT), the Children's cancer and Leukaemia Group (CCLG), and British Infection Association (BIA). Miller P, Patel SR, Skinner R, Dignan F, Richter A, Jeffery K, Khan A, Heath PT, Clark A, Orchard K, Snowden JA, de Silva TI.J Infect. 2022 Nov 15:S0163-4453(22)00646-6.
  • The COVID19 Pandemic has Changed Women's Experiences of Pregnancy in the UK. Sturrock S, Turner K, Lee-Wo C, BSc VG, Khalil A, Heath PT, Doare KL. Matern Child Health J. 2023 Sep;27(9):1445-1449
  • Transmission of mpox in educational settings and risk of severe disease in children and adolescents-Let's not make the same mistakes as COVID-19 again. Karampatsas K, Khalil A, Heath PT, Doare KL, Ladhani SN. Rev Med Virol. 2023 Jun 21:e2467.
  • Long-term impact of serious neonatal bacterial infections on neurodevelopment. Thomas R, Bijlsma MW, Gonçalves BP, Nakwa FL, Velaphi S, Heath PT. Clin Microbiol Infect. 2023 Apr 19:S1198-743X(23)00190-8
  • Safety, efficacy, and immunogenicity of the NVX-CoV2373 vaccine. Underwood E, Dunkle LM, Madhi SA, Gay CL, Heath PT, Kotloff KL, Smith K, Chau G, Galbiati S, McGarry A, Woo W, Cho I, Alves K, Áñez G, Bennett C, Shinde V, Fries L, Mallory RM, Glenn GM, Toback S. Expert Rev Vaccines. 2023 Jan-Dec;22(1):501-517.
  • Update on Vaccines in Antenatal Care. Galiza EP, Khalil A, Heath PT. Pediatr Infect Dis J. 2023 Dec 27.
  • Booy R, Heath PT, Willocks L, Mayon-White R, Slack M, Moxon ER. Invasive Pneumococcal Infections in Childhood. Lancet 1995;345:1245-6.
  • Heath PT, Booy R, Slack MPE, Moxon ER. Are Hib booster vaccinations redundant? Lancet 1997;350:817.
  • Rushdy A, Ramsay M, Heath PT, Azzopardi H, Slack M. Infant Hib vaccination and herd immunity. Journal of Paediatrics1999;134(2):253-4
  • McCartney AC, Heath P, Hughes R, Mifsud A, Price E. The ORACLE I and II randomised trial results do not remove the need for prophylaxis against early onset Group B streptococcal disease. BJOG. 2002 Dec;109(12):1419-20.
  • Finn A, Booy R, Moxon R, Sharland M, Heath P. Conflicting advice. Arch Dis Child. 2003 Feb;88(2):176.
  • McVernon, Ramsay, Heath, Slack, Moxon. Haemophilus influenzae type b epiglottitis. Article gives timely lesson. BMJ 2003;326:284
  • Ramsay ME, Miller E, Andrews N, Slack M, Heath P. Epidemiological data are essential (Rapid response). BMJ, 16 December 2004.
  • Patel SR, Cohen B, Brown D, Heath PT. Reply to Arya and Agarwal and Meisel and Dilloo. Clin Infect Dis. 2007 Aug 1;45(3):398-399
  • Stenson B, Heath PT, Bedford Russell A. Respiratory Distress Related to Asymptomatic Colonisation with Group B Streptococci. PIDJ 2007; 26:765.
  • Expediting clinical trials in a pandemic. Pollard AJ, Reiner A, John T, Sheasby E, Snape M, Faust S, Collinson A, Finn A, Heath PT, Miller E. BMJ. 2009 Nov 10;339:b4652.
  • Bate J, Chisholm J, Skinner R, Breuer J, Ramsay M, Wheatley K, Hambleton S, Heath PT. Varicella postexposure prophylaxis in children with cancer: urgent need for a randomised controlled trial. Arch Dis Child. 2012 Sep;97(9):853-4
  • Heath PT. Rapid Response. Re: Introducing a new group B meningococcus vaccine. 23 April, 2014. (http://www.bmj.com/content/348/bmj.g2415/rr/695395)
  • DeNIS collaboration: setting the future research agenda. Mathur S, Li G, Folgori L, Sharland M, Heath PT. Lancet Glob Health. 2017 Jan;5(1):e36
  • Authors' reply re: Prevention of early-onset Group B streptococcal disease. Green-top Guideline No. 36. Hughes R, Brocklehurst P, Steer P, Heath PT, Stenson B. BJOG. 2018 Jul;125(8):1041-1042

 

 

 

see cnpi.org.uk/research/ for further information

 

Find a profileSearch by A-Z